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ABSTRACT
Enterohemorrhagic Escherichia coli (EHEC), also known as Shiga toxin-producing 
E. coli (STEC) or verocytotoxigenic E. coli (VTEC), is a food- and waterborne 
pathogen that spreads also by zoonotic or person-to-person transmission route 
causing severe enteric infections. A typical symptom of EHEC infection in humans 
is bloody diarrhea but the infection may lead to severe complications as thrombotic 
microangiopathy, known also as hemolytic uremic syndrome (HUS) or thrombotic 
thrombocytopenic purpura (TTP), or even death. Globally, the most significant 
serotype has been EHEC O157:H7. However, among shigatoxigenic E. coli,
approximately 450 O:H serotypes have been described. Of these, over 200 have 
been associated with human infections. During the past decade, the prevalence of 
human EHEC non-O157 infecions has increased in several countries.  
The aim of this study was to gain epidemiological knowledge and data on pheno- 
and genotypic characteristics of EHEC O157 and non-O157 strains isolated from 
humans in Finland. For the analysis, all those EHEC strains isolated during 1990–
2002 were investigated. In addition, three E. coli O157 strains lacking the stx genes 
were included. The strains were differentiated for virulence-associated genes (stx,
stx variants, eae and its subtypes, efa, cdt, EHEC-hlyA, etpD, katP, espP, and sfpA)
by molecular genetic methods. Also, phenotypic tests for other microbial 
characteristics (O:H serotype, phage type, Stx-, Ehly-, and CDT-production) were 
used. The pheno- and genotypic properties were analyzed for epidemiological 
surveys of the EHEC O157 and non-O157 strains. In addition, the virulence profiles 
of the EHEC strains were studied in relation to the clinical picture of the patients 
and the geographical prevalence of the domestic infections was investigated. In-
depth interviews of the infected people were explored to detect putative sources of 
human EHEC infections. Furthermore, the clonality of nonmotile, sorbitol-
fermenting (SF) E. coli O157 strains was compared to the SF E. coli O157 strains 
occurring in Germany.  
During the study period, 200 infections caused by strains of EHEC O157 (127 cases; 
64%) and non-O157 (73 cases; 36%) occurred in Finland. Most were of domestic 
origin: 84% of the O157 infections and 78% of the non-O157 infections. Among the 
domestic infections during 1998-2002, family-related cases accounted for half 
(49%), followed by sporadic infections (39%), and 11% was associated with three 
infection clusters. The incidence of the EHEC infections was at its highest in 1998 
(0.64 / 105 population), and lowest (0.17 / 105 population) in 2002. Only in 1998 
8was the incidence of O157 cases higher than that of the non-O157 cases. 
Geographically, most commonly indigenously acquired EHEC infections were 
found in the Helsinki Region (28% of the infections; incidence 2.0). However, the 
population-based incidence was highest in Central Ostrobothnia (8% of the 
infections; incidence 10.3). 
Only strains of the serogroup O157 caused separate infection clusters (C1-C3) 
affecting 11 people in 1998 and 2001 in Päijät-Häme (C1) and Southwest Finland 
(Varsinais-Suomi) (C1), and Southeast Finland (Kymenlaakso) (C2, C3). In pheno-
and genotypic comparison of the strains, the strain of the subtype 
O157:H7:PT2:stx2:stx2c:eae:1.1 caused three  out of  four infections in C1. The strain 
(O157:H¯:PT88:stx2:eae:1.13) was isolated from a child whose mother was infected 
with a strain of the C1 type. In C2, strains of the subtypes O157:H7:PT4:stx2:
eae:1.57 and O157:H7:PT4:stx2:eae:1.58 caused four infections. In C3, a strain of 
the subtype O157:H7:PT14:stx1,2:eae:1.67 caused all three infections. The 
implicated vehicles for these clusters were putative person-to-person or food-borne 
transmission. Interestingly, in Finland about 10% SF O157:H7/H¯ were detected. 
The pheno- and genotypic characteristics of these strains shared similar 
characteristics with strains commonly occurring in Europe, suggesting a 
transmission of the strains at European Union level. In particular, among the strains 
of O157:H¯:PT88:stx2:eae, several other determinants also supported their 
relatedness with similar strains which have recently emerged in Europe. 
Among the non-O157 strains, 34 O:H serotypes were detected. As in other European 
countries, the most common O groups among the isolates were O26, O103, and 
O145. In addition, two new EHEC serotypes (O102:H7 and O181:H49) associated 
with human infections were detected, strengthening the importance of EHEC non-
O157 strains as human pathogens. Also, seven pheno- and genotypic profiles of non-
O157 strains were found from patients suffering from HUS or TTP. However, a 
particular virulence profile of EHEC O157 group (O157:H7:PT2:stx2:stx2c:eae:Ehly) 
was significantly (P=0.02) more frequently associated with a severe clinical picture 
(bloody diarrhea, HUS, TTP) of the patients than were other profiles; the risk factors 
for severe symptoms was under 5 year-olds and infection by this type of O157:H7 
strain. Strains of this virulence profile also caused the deaths of two children.  
For EHEC, a pheno- and genotypically heterogeneous group of strains causing 
severe infectious diseases, effective surveillance is continuously needed thus 
allowing detailed early diagnostics of EHEC and preventing the spread of the 
infection. In particular, pheno- and genotypic characterization of the human EHEC 
isolates enables the sources of the infections to be swiftly traced both at national and 
international level, and helps to evaluate the putative virulence ability of the strain.  
Keywords: enterohemorrhagic, E. coli (EHEC), Shiga toxin-producing E. coli
(STEC), zoonotic pathogen, epidemiology, virulence characteristics. 
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TIIVISTELMÄ
Enterohemorraaginen Escherichia coli (EHEC), josta käytetään myös nimityksiä 
shigatoksinen E. coli (STEC)- tai verosytotoksinen E. coli (VTEC)-bakteeri, on 
elintarvike- ja vesivälitteinen patogeeni, joka leviää myös zoonoottisesti tai 
henkilöstä toiseen tapahtuvassa tartunnassa aiheuttaen vakavia 
suolistoinfektioita. Tyypillisimmin EHEC-infektio aiheuttaa ihmisillä 
veriripulin, mutta tartunta voi johtaa vakaviin komplikaatioihin kuten 
tromboottiseen mikroangiopatiaan, josta on käytetty myös termejä hemolyyttis- 
ureeminen syndrooma (HUS) tai tromboottinen trombosytopeeninen purppura 
(TTP), tai jopa kuolemaan. Maailmanlaajuisesti merkittävä EHEC serotyyppi on 
EHEC O157:H7, mutta shigatoksisessa E. coli -bakteeriryhmässä on kuvattu 
noin 450 O:H serotyyppiä. Näistä yli 200 on liittynyt humaanitartuntoihin. 
Viimeisen kymmenen vuoden aikana EHEC non-O157 humaanitartuntojen 
prevalenssi onkin noussut useassa maassa.  
Tämän tutkimuksen tarkoituksena oli saada tietoa Suomessa eristettyjen EHEC 
O157 ja non-O157 kantojen feno- ja genotyyppisistä ominaisuuksista sekä niiden 
epidemiologiasta. Tutkimuksessa analysoitiin kaikki aikavälillä 1990–2002 eristetyt 
EHEC kannat. Tutkimukseen sisällytettiin myös kolme stx-negatiivista E. coli O157 
kantaa. Kannat eroteltiin virulenssiin liittyvien geenien (stx, stx variantti, eae ja sen 
alatyypit, efa, cdt, EHEC-hlyA, etpD, katP, espP ja sfpA) perusteella 
molekyyligeneettisin menetelmin. Muiden ominaisuuksien (O:H serotyyppi, 
faagityyppi, Stx-, Ehly- ja CDT-tuotto) karakterisoimiseksi käytettiin fenotyyppisiä 
testejä. Feno- ja genotyyppiset ominaisuudet analysoitiin EHEC O157 ja non-O157 
kantojen epidemiologista tutkimusta varten. Lisäksi EHEC-kantojen 
virulenssiprofiilit tutkittiin suhteessa potilaiden kliiniseen kuvaan ja kotimaisten 
tartuntojen maantieteellinen esiintyvyys kartoitettiin. EHEC-tartunnan saaneiden 
ihmisten syvähaastattelut analysoitiin etsittäessä mahdollisia EHEC-tartunnan 
lähteitä. Myös liikkumattomien, Suomessa esiintyvien sorbitoli-positiivisten (SF) E. 
coli O157 kantojen samankaltaisuutta verrattiin vastaaviin Saksalaisiin kantoihin.  
Tutkimusaikavälillä Suomessa esiintyi 200 EHEC-tartuntaa: 127 (64%) EHEC 
O157- ja 73 (36%) non-O157-tartuntaa. Suurin osa tartunnoista oli kotimaista 
alkuperää: 84% O157-tartunnoista ja 78% non-O157-tartunnoista. Kotimaisista 
tartunnoista vuosina 1998–2002 noin puolet (49%) oli perheensisäisiä tartuntoja, 
yksittäistapauksia oli 39% ja 11% liittyi kolmeen tartunta-ryppääseen. EHEC  
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-tartuntojen esiintyvyys oli korkeimmillaan vuonna 1998 (0.64 / 105 populaatio), ja 
alhaisemmillaan (0.17 / 105 populaatio) vuonna 2002. Vain vuonna 1998 O157 
tapausten esiintyvyys oli korkeampi kuin non-O157 tapausten. Kotimaista alkuperää 
olevat EHEC tartunnat havaittiin pääasiallisesti Helsingin seudulla (28% 
tartunnoista; esiintyvyys 2.0), mutta esiintyvyys oli korkein Keski-Pohjanmaalla 
(8% tartunnoista; esiintyvyys 10.3). 
Ainoastaan seroryhmän O157 kannat aiheuttivat erillisiä tartuntaryppäitä (C1-C3), 
jotka liittyivät 11 tartuntaan vuosina 1998 ja 2001 Päijät-Hämeessä (C1), Varsinais-
Suomessa (C1), ja Kymenlaaksossa (C2, C3). C1 ryppääseen liittyvien kantojen 
feno- ja genotyyppisessä vertailussa tyyppiä O157:H7:PT2:stx2:stx2c:eae:1.1 oleva 
kanta aiheutti kolme tartuntaa neljästä. Neljäs, O157:H-:PT88:stx2:eae:1.13 -kanta 
eristettiin lapselta, jonka äidillä oli edellämainitun C1 tyypin aiheuttama tartunta. C2 
ryppäässä tyyppien O157:H7:PT4:stx2:eae:1.57 ja O157:H7:PT4:stx2:eae:1.58 
kannat aiheuttivat neljä tartuntaa. C3 ryppäässä tyypin O157:H7:PT14:stx1,2:
eae:1.67 kanta aiheutti kaikki kolme tartuntaa. Ryppäiden C1-C3 vehikkeleiksi 
osoitettiin mahdollinen henkilöstä toiseen tapahtunut tai elintarvikevälitteinen 
tartunta. Mielenkiintoisesti, Suomessa havaittiin myös 10% SF O157:H7/H-
kantojen aiheuttamia tartuntoja. Näiden kantojen feno- ja genotyyppiset 
ominaisuudet olivat samankaltaisia Euroopassa yleisesti esiintyvien SF O157:H7/H-  
kantojen kanssa, viitaten kyseisten kantojen levinneisyyteen Euroopan Unionin 
alueella. Erityisesti, O157:H-:PT88:stx2:eae kannoilla useat tekijät tukivat kantojen 
sukulaisuutta samantyyppisiin, lähiaikoina Euroopassa esiintyviin kantoihin. 
Non-O157 kannat tyypittyivät yhteensä 34 O:H serotyyppiin. Kuten muissakin 
Euroopan maissa, kantojen yleisimmät O ryhmät olivat O26, O103, ja O145. Myös 
kaksi uutta humaanitartuntoihin liittyvää EHEC serotyyppiä (O102:H7 ja 
O181:H49) löydettiin, mikä vahvistaa EHEC non-O157 kantojen tärkeää asemaa 
humaani-patogeeneina. Myös seitsemän erilaista non-O157 kantojen feno- ja 
genotyyppiprofiilia löydettiin kannoista, jotka oli eristetty HUS tai TTP-potilailta. 
Kuitenkin, verrattuna kaikkiin muihin profiileihin, EHEC O157 virulenssiprofiili 
O157:H7:PT2:stx2:stx2c:eae:Ehly liittyi tilastollisesti merkitsevästi (P=0.02) 
useammin potilaiden vakavaan taudinkuvaan (veriripuli, HUS, TTP). Vakavan 
taudinkuvan riskitekijäksi muodostui potilaan alle viiden vuoden ja tämän O157:H7 
kantatyypin aiheuttama tartunta. Kyseisen virulenssiprofiilin omaavat kannat 
aiheuttivat myös kahden lapsen kuoleman.  
EHEC-kannat, jotka ovat feno- ja genotyyppisesti heterogeeninen, vakavia tarttuvia 
tauteja aiheuttava patogeeninen ryhmä, edellyttävät jatkuvaa tehokasta 
diagnosointia, joka mahdollistaa yksityiskohtaisen, varhaisen EHEC tartuntojen 
toteamisen ja uusien tartuntojen ennaltaehkäisemisen. Erityisesti EHEC kantojen 
feno- ja genotyyppien karakterisointi mahdollistaa tartuntalähteiden nopean 
jäljitettävyyden sekä kansallisella että kansainvälisellä tasolla ja lisäksi edesauttaa 
EHEC kantojen mahdollisten virulenssiominaisuuksien arviointia.  
Avainsanat: enterohemorraaginen E. coli (EHEC), shigatoksinen E. coli (STEC), 
zoonoosi, epidemiologia, virulenssiominaisuudet 
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RKI Robert Koch Institute, Germany 
RPLA Reversed passive latex agglutination 
RTX Repeats in toxin 
SF Sorbitol fermenting 
ShET1 Shigella enterotoxin 1 
SI Similarity index 
SLT Shiga-like toxin 
SLTEC Shiga-like toxin producing E. coli
SSI Statens Serum Institute, Denmark 
SMAC Sorbitol MacConkey agar 
Sor Sorbitol 
ST Heat-stabile toxin  
STEC Shiga toxin-producing E. coli
Stx Shiga toxin   
Tir Translocated intimin reseptor 
ToxB Clostridial toxin 
TTP Thrombotic thrombocytopenic purpura 
UV Ultraviolet 
VT Verotoxin  
VTEC Verotoxin-producing E. coli
R O Rough 
VNTR Variable number tandem repeats 
WHO World Health Organization 
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INTRODUCTION 
Diarrheal diseases transmitted by enteric pathogens are major causes of morbidity 
and mortality in humans (Kaur et al. 2003). Globally, over 2 million deaths related 
to diarrhea occur each year, particularly among under five-year old children (Clarke 
et al. 2003, www.who.int). In Finland, 500, 000 people are estimated to suffer from 
gastrointestinal illnesses annually (Pönkä 1999).  
Among diarrheagenic pathogens, Shiga toxin-producing (Stx), enterohemorrhagic 
Escherichia coli (EHEC) are described as a heterogeneous group of highly 
pathogenic bacteria with very low infective dose; even 1-100 cells are capable of 
causing disease (Griffin 1998, Jaeger and Acheson 2000). For the first time, EHEC 
emerged as human pathogens in the USA in the early 1980s during large-scale 
outbreaks of hemorrhagic colitis and hemolytic uremic syndrome (HUS) caused by 
shigatoxigenic, non-sorbitol fermenting (NSF) strains of E. coli O157:H7 (Karmali 
et al. 1983a, 1983b, Riley et al. 1983). Ever since, strains of NSF E. coli O157:H7 
have been epidemiologically, microbiologically, and clinically important worldwide. 
In addition, a new lineage, a sorbitol-fermenting (SF) nonmotile (H¯) O157, was 
identified as the cause of outbreaks of HUS in Germany in 1988 (Karch et al. 1990, 
Ammon et al. 1999, Robert Koch-Institut 2002). Recently, strains of this phenotype 
have emerged in several other European countries (Karch and Bielaszewska 2001), 
and in Australia (Bettelheim et al. 2002). Currently, among all known Stx producing 
E. coli, over 450 O:H serotypes of human and non-human origin have been detected 
(Blanco et al. 2004, www.microbionet.com.au). Of these non-O157 serotypes, 
strains of O26:H11/H¯, O103:H2/H¯, O111:H2/H¯, and O145:H28/H¯ deserve 
special mention by causing outbreaks, as well as in association with severe illnesses 
(Schmidt et al. 2001). 
In addition to EHEC, five well-described pathogroups of E. coli with different 
virulence mechanisms have been associated with human diseases: enteropathogenic 
E. coli (EPEC), enterotoxigenic E. coli (ETEC), enteroinvasive E. coli (EIEC), 
enteroaggregative E. coli (EAEC), and diffusely adherent E. coli (DAEC) (Kaper et 
al. 2004). Virulence mechanisms that characterize the pathogroups of E. coli are 
genetically determined by chromosomally located factors (pathogenecity islands, 
chromosomally inserted bacteriophages) or extra-chromosomal elements (plasmids) 
that encode diarrhea-associated characteristics like colonization ability, production 
of toxins and hemolysins (Aranda et al. 2004, Kaper et al. 2004). The main virulence 
factor of EHEC bacteria has been concluded to be a production of Stx toxin(s) (Stx1 
and/or Stx2) or their variants encoded by the stx genes. However, the pathogenesis 
of EHEC bacteria is considered multifactorial and several augmenting virulence-
factors have been described (Paton et al., 2001, Kaper et al. 2004, Paton et al. 2004, 
Thorpe et al. 2004). Of other diarrheagenic E. coli, EPEC have caused, especially in 
developing countries, large outbreaks of infantile watery diarrhea by causing 
attaching and effacing lesions (A/E encoded by eae) in intestinal epithelial cells 
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(Donnenberg et al. 1993). ETEC has been the most common E. coli group associated 
with tourist diarrhea with production of heat labile (LT) and/or stable (ST) toxin 
encoded by respective lth and sta genes (Holmgren and Svennerholm 1992, 
Koprowski et al 2000, Olasz et al. 2005). Unlike other diarrheagenic E. coli strains, 
EIEC characteristically cause Shigella-like invasive infection also producing 
plasmid (pINV) mediated proteins encoded by ipa, ial genes, typically leading to 
bloody diarrhea (Sethabutr et al. 1993, Nataro and Kaper 1998, Aranda et al. 2004, 
Schmidt and Hensel 2004). Strains of EAEC group are recognized by aggregative, 
localized adherence (LA; encoded by bfpA) of the bacterial cells on the microvilli 
and a production of EAEC toxin (EAST). DAEC, also known as cell-detaching E. 
coli, are characterized by diffuse adherence to epithelial cells, possession of adhesin 
fimbria encoded by a fragment of daaC gene, ?-hemolysin production, and cytotoxic 
necrotising factor 1 (Nataro and Kaper 1998, Clarke 2001). In addition, the 
cytolethal distending toxin (CDT)-producing E. coli forms the latest group of enteric 
pathogens (Clarke 2001).  
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REVIEW OF THE LITERATURE 
1. Escherichia coli in health and disease 
Escherichia coli was first described by the German pediatrician Dr. Theodor 
Escherich as Bacterium coli commune that had been isolated from the feces of a 
healthy infant (Escherich 1885, Sussman 1985). Even today, E. coli is said to be the 
most abundant of the facultative anaerobic species of the normal human enteric 
microbiota in feces: the enterobacteria are present at about 108–109 / g, E. coli being 
the most important species (Bettelheim et al. 2003). This symbiosis provides a 
nourishing environment for bacteria, offers essential nutrients to the intestinal 
epithelium and promotes healthy immune responses in the host. In addition, E. coli
is known to affect the synthesis of vitamin K in the host. Certain E. coli strains 
might also serve as an important factor for inhibition of the growth of 
enteropathogens (Kruis 2004). Moreover, E. coli is also capable of surviving in the 
environment, water, and food, and spreading efficiently (Faiella-Tommasino and 
Reigert 2002). 
Thousands of serotypes of E. coli species, in the Escherichia genus, within the 
family of Enterobacteriaceae, form the intestinal bacterial group described as gram-
negative, non-sporulating facultative anaerobic rod, usually motile by peritrichous 
flagella (Ørskov and Ørskov 1983). Pathogenic E. coli that do not belong to the 
normal microbiota, harbor virulence factors, such as adhesins, invasins, entero- and 
cytotoxins encoded by extrachromosomal plasmids, chromosomal pathogenicity 
islands, or bacteriophage integrated virulence factors for defeating host defences in 
order to cause intestinal and extra-intestinal diseases (Kaper et al. 2004). In clinical 
microbiology, E. coli has been the most commonly isolated facultative anaerobic 
gram-negative rod in feces, and a common cause for intestinal and extra-intestinal 
infections. The most common clinical outcomes of infection caused by pathogenic 
E. coli have been urinary tract infection, sepsis and meningitis, and enteric diarrheal 
disease (Kaper et al. 2004).  
1.2 Classification of diarrheagenic E. coli
According to epidemiologic data and pathogenic characteristics, enteropathogenic E.
coli (EPEC), enterotoxigenic E. coli (ETEC), enteroinvasive E. coli (EIEC), 
enteroaggregative E. coli (EAEC), diffusely adherent E. coli (DAEC), and 
enterohemorrhagic E. coli (EHEC) have been validated as the main diarrheagenic E. 
coli pathogroups (Table 1). In addition, with conflicting data, CDT-producing E.
coli (CDT-EC) are said to be one diarrheal E. coli group (Clarke 2001, Kaper et al. 
2004, Torres et al. 2005).  
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EPEC were first reported in 1945 by John Bray as “Bacillus coli nepolitanum”,
causative agent of summer diarrhea in infants (Chen and Frankel 2004). Even today, 
EPEC is a common agent for diarrhea in children in developing countries with a 
mortality of even 30%, and sporadic EPEC infections appear in industrial countries 
of considerable concern. However, in industrialized countries, outbreaks caused by 
EPEC have been rare (Bopp et al. 2003, Kaper et al. 2004), and in Finland, since the 
1940s, only one outbreak caused by EPEC has been reported in 1987 (Viljanen et al. 
1990). The identification of this pathogen has previously been based on the 
serotyping, typical O groups being O26, O55, O86, O111, O114, O119, O125, 
O126, O127, O128, O142 (Bopp et al. 2003, Gomes et al. 2004). Nowadays, the 
hallmark of EPEC is the ability to form chromosomally by eae gene-encoded 
attaching and effacing (A/E) lesion in host cells and lack of Stx production (Kaper 
1996, Chen and Frankel 2004). In addition, strains expressing plasmidal EPEC 
adherence factor (EAF) mediated by bundle-forming pili (BFP), have been defined 
as typical EPEC and strains lacking the EAF-plasmid have been designated as 
atypical EPEC (Kaper 1996, Trabulsi et al. 2002, Chen and Frankel 2004). In 
industrial countries, the prevalence of atypical EPEC has been higher compared to 
that in developing countries (Afset et al. 2003, Kaper et al. 2004).  
ETEC strains were associated with human diarrheal illnesses in 1960s (Taylor et al. 
1961, Nataro and Kaper 1998). Ever since, the occurrence of ETEC infection has 
been high in developing countries, it has been the common agent for tourist diarrhea, 
and a cause for occasional outbreaks in industrialized countries (Naimi et al. 2003). 
In Finland, the occurrence of ETEC infections has not been endemic (Keskimäki et 
al. 2000). During pathogenesis, ETEC colonizes intestinal epithelium using fimbrial 
colonization factors (CFs) and the related colonization factor antigens (Kaper et al. 
2004). In addition, ETEC strains produce plasmid encoded heat-stable (ST) and/or 
heat-labile (LT) toxin (Nataro and Kaper 1998). The ST and LT toxins have been 
divided into subgroups Sta, STb and LT-I, LT-II, respectively. Of these, LT-I shares 
75% amino acid similarity with cholera toxin (Nataro and Kaper 1998, Kuhnert et 
al. 2000). Moreover, some strains of the ETEC group have produced EAST1, a toxin 
characteristic for the EAEC group (Savarino et al. 1996).  
EIEC was first described in 1944 as a paracolon bacillus, later identified as E. coli
O124 (Lan et al. 2004). In 1971, EIEC strains were associated with diarrheal 
diseases (DuPont et al. 1971), bloody diarrhea being typical of EIEC infection, and 
the occurrence being high in poor countries (Beutin et al. 1997, Nataro and Kaper 
1998, Sarantuya et al. 2004). EIEC strains are generally nonmotile and only a few O 
groups including O28ac, O29, O112ac, O121, O124, O135, O136, O143, O144, 
O152, O159, O164, O167, and O173 have been found (Cheasty et al. 1983, Lan et 
al. 2004). EIEC strains invade and multiply within enterocytes, causing the death of 
these hosts (Escobar-Paramo et al. 2003, Thiem et al. 2004). The invasive character 
of EIEC is governed by a 140 MDa invasivity plasmid (pInV), which encode a type 
III secretion system (TTSS) and respective TTSS effector proteins. The TTSS is also 
homologous to that of Salmonella and Yersinia (Sansonetti 1992, Sethabutr et al. 
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1993, Nataro and Kaper 1998, Lan et al. 2004, Schmidt and Hensel 2004). In 
addition, striking phenotypic and genotypic similarities have related EIEC strains 
with Shigella spp (Escobar-Paramo et al. 2003, Lan et al. 2004). 
EAEC, previously known as EAggEC, has been recognized as an important agent of 
acute and prolonged diarrhea especially in children of developing world, a common 
cause of travelers’ diarrhea, and increasingly an agent of outbreaks in developed 
countries since 1987 (Itoh et al. 1997, Nataro and Kaper 1998, Okeke and Nataro 
2001, Huang et al. 2004, Nataro 2005). However, in Finland, only sporadic 
infections have occurred (Keskimäki et al. 2001). EAEC strains are a highly 
heterogeneous group consisting of about 90 identified serotypes, the most common 
being O15:H18, O44:H18, O77:H18, O111:H12, O125, and O126 (Okeke and 
Nataro 2001). EAEC are defined by their aggregative adherence to intestinal 
epithelial cells in a characteristic “stacked-brick” pattern (Nataro and Kaper 1998). 
During pathogenesis, EAEC have adhered to the intestinal mucosa by plasmid 
encoded aggregative adherence fimbria (AAF/I–AAF/III), increased production of a 
mucus biofilm, mucosal toxicity due to inflammation, and cytokine release (Huang 
et al. 2004, Torres et al. 2005). Other virulence factors of EAEC have been 
plasmidal enterotoxin (PET) (Eslava et al. 1998) and enteroaggregative heat stable 
toxin 1 (EAST-1) (Kuhnert et al. 2000, Okeke and Nataro 2001, Zhou et al. 2002). 
Also, some strains of EHEC have produced EAST-1 (Karch et al. 1999b). 
DAEC, also known as cell-detaching E. coli, have caused diarrhea particularly in < 
12 months-old children and has been an important pathogens in developed countries 
(Nataro and Kaper 1998, Clarke 2001, Kaper et al. 2004). Little is known of their 
exact pathogenesis but DAEC strains are characterized by their diffuse adherence 
pattern on epithelial cells, production of ?-hemolysin and cytotoxic necrotising 
factor 1 (Clarke 2001). In addition, fimbrial adhesin F1845 mediated by both 
chromosome and plasmid, and plasmid encoded adhesin (AIDA-1) have been 
involved in diffuse adherence phenotype (Kaper et al. 2004, Torres et al. 2005). 
CDT-EC has been designated as enteric pathogens with conflicting evidence for 
pathogenesis (Clarke 2001). In pathogenicity model, the CDT toxin has caused cell 
cycle arrest and subsequent death in eukaryotic cells (Clarke 2001, Bielaszewska et 
al. 2005). Also other diarrheagenic E. coli strains, EPEC, EAEC (Clarke 2001, Clark 
et al. 2002), and SF EHEC O157:H¯ strains (Janka et al. 2003) have produced this 
toxin. In contrast, CDT has rarely been characteristic for strains of NSF E. coli
O157:H7 (Janka et al. 2003).  
EHEC bacteria were first discovered in 1977 by the production of cytotoxin, 
verotoxin (VT), lethal to Vero (African green monkey) cells, which led to these 
pathogens being called verocytotoxigenic E. coli (VTEC) (Konowalchuk et al. 
1977). In following studies of purificaton and characterization of verotoxin, O’Brien 
et al. (1982, 1983a, 1983b, 1984, 1987) observed a striking similarity with a 
structure and biological activity of the verotoxin and Stx toxin produced by Shigella 
dysenteriae type 1. This new toxin could also be neutralized by anti-Stx, and 
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subsequently it was called Shiga-like toxin (SLT). It was also observed that there 
were two major classes of SLT toxins: SLT-I and SLT-II known also as VT1 and 
VT2. Currently, these toxins have been also designated as Stx1 and Stx2, and have 
been found to include numerous variants (Nataro and Kaper 1998, Paton and Paton 
1998, Kaper et al. 2004). 
In early studies, E. coli strains isolated from diarrheal patients produced Stx but no 
significant proof of etiological significance of EHEC in diarrheal diseases or the 
possible pathogenetic significance of Stx was available (Karmali et al. 1989). In 
1982, EHEC was clearly associated with human infectious diseases when 
shigatoxigenic E. coli serotype O157:H7 was identified as a cause of two outbreaks 
of hemorrhagic colitis in the USA (Riley et al. 1983). Almost simultaneously, a 
severe clinical outcome of the patients, hemolytic uremic syndrome (HUS), was 
associated with fecal cytotoxin and cytotoxin-producing E. coli in stools (Karmali et 
al. 1983a, 1983b). Moreover in Canada, Johnson et al. (1983) independently 
reported that E. coli O157:H7 strains isolated from patients with hemorrhagic colitis 
produced a cytotoxin active on Vero cells. Ever since, EHEC have been of 
considerable concern not only because of severity of the illness they can cause, but 
also the low infectious dose and increasing incidence worldwide: currently about 
450 O:H serotypes of shigatoxigenic E. coli have occurred (Duffy et al. 2001, 
Blanco et al. 2004).  
EHEC bacteria have acquired several chromosomal and plasmidal virulence factors. 
However, production of Stx1 and/or Stx2 or their variants encoded by phage-
mediated chromosomally located stx genes is considered a main virulence factor 
(O’Brien et al. 1983a 1983b, Duffy et al. 2001). Adhesion mechanisms or 
production of other toxins, such as enterohemolysin (Ehly) or CDT, have been 
identified as augmenting virulence factors (Kaper et al. 2004). However, the 
nomenclature of EHEC and the Stx family is a complex issue (Acheson et al. 1999, 
Scheutz et al. 2001). The term enterohemorrhagic Escherichia coli (EHEC) was 
originally used to denote the Shiga-like toxin-producing E. coli (SLTEC) or Shiga 
toxin-producing E. coli (STEC), synonymous with the verocytotoxigenic E. coli 
(VTEC) (Nataro and Kaper 1998, Feng et al. 2005). For example, EHEC have been 
designated as a subset of STEC most of which carry an eae gene encoding intimin 
and are pathogenic to humans (Tarr et al 2005). According to the World Health 
Organization (WHO 1998), EHEC is defined as Stx-producing E. coli bacteria.
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2. EHEC infection in humans 
The infectious dose of EHEC bacteria has been estimated to be low: just 1-100 cells 
of the strains of serogroup O157 have been reported to cause infection (Griffin 1998, 
Jaeger and Acheson 2000). The low infectious dose enables the effective spreading 
of this pathogen via food, water or animal transmission. In addition, person-to-
person transmission of EHEC bacteria has been important (Bell 2002). The high 
mortality associated with EHEC infection has differentiated this organism from the 
infections caused by, for example, EPEC, ETEC, and EAEC (Law 2000).  
The main symptom of human EHEC infection is watery and bloody diarrhea but the 
disease may progress especially in children and elderly people to HUS, thrombotic 
thrombocytopenic purpura (TTP), and even death (Karmali et al. 1983a, 1983b, 
Riley et al. 1983, Karmali 1989, Ludwig et al. 2001, Caprioli et al. 2005). HUS or 
TTP cause complications in about 10% of the cases of E. coli O157 infection and are 
responsible for a mortality rate of 2–10% (Ahmed and Donaghy 1998). However, 
asymptomatic carriages have also been reported mainly in adults (Stephan and 
Untermann 1999). In the treatment of EHEC-infection, no specific antimicrobial 
medication is recommended (Tarr et al. 2005), since the use of antimicrobial agents 
may lead to an increase of Stx production (Herold et al. 2004). 
2.1 Occurrence of EHEC infections
Since the first EHEC O157:H7 outbreaks in the USA in the early 1980s, there has 
been a dramatic increase in the number of reported infections caused by this O group 
in the developed countries (Nataro and Kaper 1998), and reports from Africa (Effler 
et al. 2001) have shown that rates of O157:H7 infections in countries lacking 
diagnostic capabilities might be underestimated (Tarr et al. 2005). Annual incidence 
rates of ? 8 / 105 of population have been reported in regions of Scotland, Canada, 
and the USA (Mead and Griffin 1998). Also, outbreaks with hundreds of cases of 
EHEC infection have been reported from the United Kingdom (Gillespie et al. 2005) 
and North America, and outbreaks affecting several thousands of individuals have 
occurred in Japan, where over 9,000 children were infected (Michino et al. 1998). In 
addition, in Scotland severe, fatal outbreaks with 21 deaths among over 400 
individuals infected with the E. coli O157:H7 have occurred (Ahmed and Donaghy 
1998).  Moreover, an international outbreak caused by EHEC O157 has occurred 
among tourists belonging to five nationalities visiting Fuerteventura, Spain (Pebody 
et al. 1999). Of European countries, the incidence of O157 infections has been high 
(1.3–2.1 / 105 of population during 1995–1998) in England and Wales (Tozzi et al. 
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2001, Willshaw et al. 2001). The first outbreak of EHEC O157 in Scandinavia 
occurred in Sweden in 1995, affecting about 100 people (Ziese et al. 1996). In 
Finland, with a population of 5.1 million, the incidence rate of EHEC O157 
infections has ranged from 0.06 in 1990 to 1.0 in 1997 (Keskimäki et al. 1998). In 
1997, the first outbreak of EHEC O157 also occurred (Paunio et al. 1999).  
The emergence of SF EHEC O157:H? occurred in Germany in the late 1980s in the 
form of several outbreaks (Karch et al. 1990, Ammon et al. 1999, Karch and 
Bielaszewska 2001, Robert Koch-Institut 2002). Even recently, these variants have 
been identified as the second most common cause of sporadic cases of HUS in 
Germany (Friedrich et al. 2002, Gerber et al. 2002). In addition, these organisms 
have occurred in the Czech Republic (Bielaszewska et al. 1998), Austria 
(Allerberger et al. 2000, Gerber et al. 2002), and the UK (Allison 2002, Taylor et al. 
2003). In Finland, the first SF STEC O157:H? strain was detected in 1997 
(Keskimäki et al. 1998). Outside Europe, SF E. coli O157:H? strains have been 
detected especially in Australia (Bettelheim et al. 2002). In addition, nonmotile 
strains of O157 group have occurred in the USA (Mohle-Boetani et al. 2001, 
Feldman et al. 2002) and the UK (O’Brien et al. 2001). However, commonly the 
strains especially in the USA have been pheno- and genotypically different from the 
German isolates. 
The implication of EHEC non-O157 has been increasing over the past 10 years in 
human infections (Scheutz et al. 2004). Currently, among 450 EHEC non-O157 
serotypes (Blanco et al. 2004, www.microbionet.com.au), the predominant O groups 
associated with human diseases have been O26, O91, O103, O111, O128, O145, and 
O121 (Bettelheim 2000, Prager et al. 2002, Blanco et al. 2004). The prevalence of 
EHEC non-O157 infections has been higher than those of O157 especially in 
continental Europe (Caprioli and Tozzi 1998, Gerber et al. 2002), Australia (Elliott 
et al. 2001), Latin America (Blanco et al. 2004), and Denmark (Scheutz et al. 2005). 
In Australia, EHEC strains of serotype O111:H? have caused an outbreak affecting 
more than 200 people (Paton et al. 1996). With regard to other continents, it has 
been estimated that 25–50% have been caused by strains of the EHEC non-O157 
group in the USA (Thorpe 2004), and strains of EHEC non-O157 associated with 
human illnesses have recently been detected in developing countries (Khan et al. 
2002a, 2002b). In addition, non-O157 infections have played an important role in 
Argentina, Chile, and South Africa (Blanco et al. 2004). In Germany, Italy, and the 
United Kingdom, strains of EHEC non-O157 have caused 10 to 30% of the HUS 
cases (Caprioli et al. 1997). Also, in other studies, dozens of serotypes have been 
associated with the EHEC infections or HUS (Beutin et al. 1998, Goldwater and 
Bettelheim 2000, Evans et al. 2002, Jenkins et al. 2003, Blanco et al. 2004). With an 
addition to the growing list of strains of human pathogenic EHEC non-O157, recent 
studies have identified O117:H7 as a new EHEC non-O157 serotype (Olesen et al. 
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2005). Moreover, variants not serotyping with antisera against the estabilished O 
groups have occurred (Jenkins et al. 2003). 
2.2 Sources and vehicles of EHEC infections 
The principal reservoir of EHEC O157 and non-O157 bacteria is considered to be 
the gastrointestinal tract of healthy cattle and other ruminants like sheep and goats. 
In addition, domestic animals such as cats, dogs, and rabbits (Garcia and Fox 2003) 
have been sources of EHEC. Human infections or outbreaks have also been 
associated with a wide variety of food items; undercooked ground beef, hamburgers, 
dry fermented sausage, unpasteurized milk or surface contaminated fruit and 
vegetables. In addition, untreated or contaminated drinking water or swimming 
water have been causative agents for the EHEC infection, and also person-to-person 
transmission has been important (Nataro and Kaper 1998, Paton and Paton 1998, 
Jaeger and Acheson 2000, Kaper et al. 2004). Nosocomial and laboratory-acquired 
infections have also been reported (Coia 1998a, 1998b, Welinder-Olsson et al. 
2003). In Finland, the first outbreak of EHEC O157:H7 in 1997 was associated with 
swimming in a lake (Paunio et al. 1999). In addition, human EHEC O157 (Lahti et 
al. 2002) and non-O157 infections (Heinikainen et al. 2004) have been traced to 
cattle. 
3. Evolution and clonality of EHEC 
The carriage of EHEC-associated virulence (Figure 1) has enabled studies on several 
research areas such as on pathogenicity, evolution, clonality and epidemiology. In 
the evolutional studies of EHEC, the key research elements have been the 
chromosomally located LEE locus encoding the attachment and effacement 
phenotype, and the stx-phage integrated chromosomal stx loci (Feng et al. 1998, 
Whittam 1998, Jores et al. 2004). According to a stepwise evolutionary model, the 
pathogenic lineage of EHEC O157 has arisen during the past 50 years from an 
EPEC ancestor of serotype O55:H7 possessing the LEE locus (Figure 2) (Whittam et 
al., 1993; Feng et al. 1998, Whittam 1998, Wick et al. 2005). Key events were the 
acquisition of the new serogroup O157 antigen -encoding gnd-rfb region, integration 
of the stx2-phages, and the large virulence plasmid (designated as pO157) (Duffy 
and Garvey 2001, Kim et al. 2001). In subsequent steps, the EPEC O157 strains 
were lysogenized by stx1 phage, lost the ability to ferment sorbitol, mutated leading 
to inactivation of the uidA gene, which resulted in a loss of ?-glucuronidase activity. 
In addition, two separate clades resulted: the groups of NSF EHEC O157:H7, and 
SF nonmotile O157:H? strains, the latter also known as a German clone (Whittam et 
al. 1993, Karch et al. 1993, Feng et al. 1998, Whittam 1998, Kim et al. 2001, 
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Monday et al. 2004, Wick et al. 2005,). Geographically, the lineage of EHEC 
O157:H7 is known as a disseminated complex of highly related genotypes (Kim et 
al. 2001), although some geographical variations of the strains have been 
documented in Europe, the USA, and Australia (Kim et al. 2001, Brüssow et al. 
2004). 
In genetic analyses, most EHEC non-O157 strains have been distantly related to the 
typical E. coli O157:H7 group called EHEC1, and form separate clades: EHEC2, 
STEC1, and STEC2 (Whittam 1998, Shaikh and Tarr 2003). EHEC2 has been 
considered the most common group among non-O157 strains, including strains of 
serotype O111:H8/H11/H?, O26:H11, or nontypeable O-groups. The STEC1 group 
includes many different O-groups and usually with H21 flagellar antigen. The most 
common serotypes have been O113:H21, O174:H21 (previously OX3:H21), and 
O91:H21. These strains have typically been negative for the carriage of the LEE. 
STEC2 is composed of strains belonging to serotypes O103:H2/H6 and O45:H2 
(Whittam 1998, Donnenberg and Whittam 2001). However, in other studies, 
similarities have occurred also between strains of the O groups O26, O15, and O103 
(Jores et al. 2004). Moreover, among the strains of O26:H11 important findings of 
genetic changes have been made: this clone has been shown to carry a pathogenicity 
island (HPI), which has homologous sequences to pathogenic Yersinia sp., and this 
HPI island is not found in the closely related O111 strains (Karch et al. 1999b), 
which may have been due to the rapid acquisition or loss of genetic material, or 
other unsolved events (Donnenberg and Whittam 2001). 
In the evolutionary studies, two highly divergent phylogenetic gene clusters (stx1
and stx2) were also described, which separated long ago and underwent most of their 
sequence evolution outside E. coli (Whittam 1998). Of these, stx1 has been highly 
conserved, and it has been postulated that this gene region first moved from S.
dysenteriae into the ancestral bacteria of EHEC2 group, accumulated several 
mutations, and then moved by transduction recently into EHEC1 O157:H7 (Whittam 
1998). Instead, the stx2 genes have expressed several variants, and in addition to E.
coli, have moved among divergent species like Citrobacter freundii and 
Enterobacter cloacae (Whittam 1998). In general, both stx1 and stx2 have provided 
an example of the rapid exchange of genetic cassettes between different E. coli
strains (Brüssow et al. 2004) and other bacteria. 
The clonality and epidemiological relationships of the EHEC O157 (Liesegang et al. 
2000, Karch and Bielaszeska 2001, Kim et al. 2001, Beutin et al. 2002) and various 
non-O157 strains (Schmidt et al. 1999a), such as O103 (Prager et al. 2002), O118 
(Wieler et al. 2000), or O145 (Sonntag et al. 2004) have also been exploited in 
studies of outbreaks or sporadic infections. In addition, the nearly 1,400 genes 
identified in E. coli O157:H7 have enhanced studies of the comparability of these 
strains (Perna et al. 2001).
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4.Virulence characteristics of EHEC
To date, several virulence factors for EHEC bacteria have been suggested, such as 1) 
Stx1 and/or Stx2 production, 2) formation of the attaching and effacing phenotype, 
3) enterohemolytic activity, 4) production of serin protease Esp, 5) presence of a 
special catalase system KatP, 6) production of ToxB protein with homolygy to large 
clostridial cytotoxins, 7) StcE metalloprotease which is transported by the etp into 
the extracellular environment, 8) a heat-stable enterotoxin (EAST) 9) adhesion 
protein Iha, 10) fimbria-associated colonization factors, 11) iron supply by hemin-
receptor and high pathogenicity island HPI, and 12) lipopolysaccharides (LPS) 
endotoxins (Tschäpe and Fruth 2001, Schmidt and Hensel 2004). In addition, the 
sequencing of the EHEC O157 bacteria has rapidly enabled the discovery of genes 
(over 1,300 genes) as their new candidates as virulence factors, alternative metabolic 
capacities, prophages, and other new functions (Hayashi et al. 2001, Perna et al. 
2001).  
4.1 Chromosomally located virulence characteristics 
The most important bacterial virulence factor of EHEC has been suggested to be the 
production of Stx1, Stx2, or their variants encoded by lysogenic, lambdoid 
bacteriophages (Melton-Celsa and O’Brien 2000). The other important virulence 
factor is possession of chromosomally located eae gene encoding intimine (the E.
coli attaching and effacing protein) that mediates the attaching of EHEC bacteria to 
the surface of epithelial cells of the intestine.  
4.1.1 Shiga toxin (Stx) and stx variants
The cardinal feature of EHEC strains is the production of Stx1 and Stx2, which are 
antigenically distinct, major groups of Stx toxin (Melton-Celsa and O’Brien 2000). 
Stx1 of EHEC bacteria is closely related to the Shiga toxin 1 produced by Shigella 
dysenteriae serotype 1 (Melton-Celsa and O’Brien 2000). Among the Stx1 and 
especially Stx2, tens of variants have been identified, the main variant groups being 
Stx1c, Stx1d, Stx2c, Stx2dac (i.e. activatable by elastase), Stx2e, Stx2f, or Stx2g 
(Melton-Celsa and O’Brien 1998, Scheutz et al. 2001, Friedrich et al. 2002, Cherla 
et al. 2003, Leung et al. 2003). Stx1 and Stx2 toxins are approximately 59% 
homologous at the amino acid sequence level, while the variants of Stx2 share 84-
99% similarity with the Stx2 (Cherla et al. 2003). The genes for the Stx group are 
either located on lambdoid bacteriophages or on the chromosome (Melton-Celsa and 
O’Brien 2000, Tschäpe and Fruth 2001, Cherla et al. 2003). In addition, EHEC may 
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express more than one Stx if carrying more than one Stx-encoding bacteriophage 
(Cherla et al. 2003). 
Stx toxins are holotoxins consisting of an A subunit and a pentameric B subunit. The 
five B subunits form a doughnut-shaped structure and the C-terminus of the A–
subunit is inserted non-covalently into this ring. In eukaryotic cell membranes, the 
receptor for Stx family members is globotriaosylceramide (Gb3) except for the pig 
edema disease toxin, Stx2e, which preferentially binds to the longer glycolipid 
globotetraosylceramide (Gb4) (Melton-Celsa and O’Brien 2000, Law 2000). Once 
bound to the target cell membrane, Stx toxin molecules are internalized via vesicles 
by endocytic mechanism of the intestinal epithelial cells, transported through the 
trans-Golgi network and Golgi apparatus to the endoplasmic reticulum and nuclear 
membrane (Cherla et al. 2003). Subsequently, the Stx A subunit is nicked by 
protease, which generates catalytically active A1 and A2 fragments. The released A1
subunit of the toxin is able to inhibit the peptide chain elongation step of protein 
synthesis leading to cell death (Law 2000). However, in some cells, the toxin 
vesicles have been degraded by lysosomes (Law 2000). In the bloodstream the Stx 
toxin is further transported into organs (for example kidneys) rich with specific Gb3 
receptors (Arab and Lingwood 1998). Although Stx1 and Stx2 have similar modes 
of action, their toxicities appear to be different. Compared to Stx1, Stx2 has been 
1,000 times more cytotoxic towards human renal microvascular endothelial cells, the 
putative target of Stx in the development of HUS (Louise and Obrig 1995, Law 
2000). 
In 1983, it was found that the genetic information for the production of Stx of E. coli
O26:H11 and E. coli O157:H7 outbreak strains was carried in lambdoid 
bacteriophages integrated in the chromosome (Melton-Celsa and O’Brien 2000, 
Herold et al. 2004). In recent years, Stxs have been found to be encoded by several 
lambdoid bacteriophages of approximately 60 Kb in size (stxA encoding the A-
subunit, stxB encoding the B-subunit), which are able to cause lysogenization of the 
host cells of various enteric bacteria, in particular E. coli (Tschäpe and Fruth 2001, 
Gamage et al. 2003). The stx genes have been associated with a specific gene region 
(late phase region) of the lambdoid phage (Neely and Friedman 1998, Unkmeir and 
Schmidt 2000, Tschäpe and Fruth 2001). When lambdoid phage DNA have 
integrated into the chromosomal genome of the bacterial host cells, the stx genes 
have remained silent under genetic control (Tschäpe and Fruth 2001) but have 
become highly expressed when phage enter the replicative or lytic cycle, resulting in 
phage production and bacterial lysis (Johnson et al. 1981, Wagner et al 2001, 
Gamage et al. 2003, Gamage et al. 2004). Induction to the lytic cycle can occur after 
exposure of the bacteria to DNA damaging agents such as antibiotics or ultraviolet 
(UV) light (Gamage et al. 2004), resulting in the release of a new generation of 
bacteriophage particles and Stx into the environment (Tschäpe and Fruth 2001). 
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The numerous variants of stx1 and stx2 have been identified, differing by only one or 
two amino acids in either the A or B subunit (Lin et al. 1993, Paton and Paton 1998, 
Bastian et al. 1998, Pierard et al. 1998). However, many different styles of 
designations have been used in nomenclature to differentiate these toxins, which has 
created a non-uniform nomenclature (Scheutz et al. 2001). Nevertheless, based on 
the genomic restriction profiles, some stx designations can be expressed as 
stx1/stx1vO111 (hereafter stx1), stx2, stx2c/stx2vha/stx2vOX393 (hereafter stx2c), stx2vhb,
stx2vO111/stx2vOX392 (hereafter stx2vO111 and stx2vOX392), stx2e, and stx2ev genes (Lin et al. 
1993, Bastian et al.1998). In addition, based on the synonyms of Stx and VT toxins, 
for example the new toxins by Pierard et al. (1998) can be designated VT2d-Ount 
(hereafter stx2d-Ount) and VT2d-OX3a (hereafter stx2d-OX3a). Of the toxin types, Stx2, 
Stx2c and Stx2dac have been the most prevalent associated with HUS patients or 
patients with severe symptoms (Friedrich et al. 2002, Prager et al. 2005). Instead, 
Stx2d-Ount variant of the B-subunit of the Stx, has been associated with human 
disease but with mild symptoms (Pierard et al. 1998). Stx2e has typically caused 
edema disease in pigs (Gyles et al. 1988, Weinstein et al. 1988). Stx2f has been 
associated mainly with feral pigeons (Schmidt et al. 2000), and Stx2g has recently 
been identified as a toxin found in bovines (Leung et al. 2003).  
However, although the Stx production is considered a main virulence factor of 
EHEC, strains of non-shiga toxin producing O157:H? E. coli have been found 
among strains isolated from patients with HUS or diarrhea (Schmidt et al. 1999b). 
Thus, yet unknown, non-Stx virulence traits causing severe symptoms in susceptible 
patients may have been present. However, also the loss of stx genes can rapidly 
occurr among some strains and a putative loss of stx genes of STEC strains during 
the storage or isolation of the strains might complicate the study of the virulence of 
these strains. These strains can appear in diagnostics only as stx negative variants 
but clinically and epidemiologically they have been stx positive strains. 
4.1.2 Locus of Enterocyte Effacement (LEE)  
Most EHEC strains harbour the pathogenicity island (PAI) of locus of enterocyte 
effacement (LEE), which encodes a type III secretion system (TTSS), responsible 
for the secretion and translocation of virulence determinants, and effector proteins 
that are homologous to those produced by EPEC (McDaniel et al. 1995, Kaper et al. 
2004). LEE is involved in the production of proteins associated with the intimate 
adherence to intestinal epithelial cells, initiation of host signal transduction 
pathways, and the formation of A/E lesions (Perna et al. 1998, Clarke et al. 2003, 
Schmidt and Hensel 2004, Torres et al. 2005). The overall sequence identity of LEE-
encoded proteins of EHEC and EPEC has been up to 94%, although the similarity of 
E. coli secreted proteins, such as EspA, EspB, EspD, intimin, and translocated 
intimin receptor (Tir), have ranged from 67% to 88% (Law 2000, Torres and Kaper 
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2002, Schmidt and Hensel 2004). Components (Esc/Sep proteins) of the TTSS form 
an apparatus for translocation of EspB, Tir and possibly other proteins into the 
eukaryotic cell (Kaper et al. 1998). Furthermore, a second cryptic TTSS, E. coli type 
III secretion system 2, has been identified, which can potentially influence the 
expression of genes within the LEE locus of E. coli O157:H7 and non-O157 
(Makino et al. 2003, Zhang et al. 2004). 
During pathogenesis, the E. coli secreted protein EspA creates a tube-like structure 
(translocon) through which other proteins, such as EspB, EspD and Tir are suspected 
to pass into the host membrane (Law 2000). After translocation, Tir spans the host 
membrane, creates a hairpin loop structure featuring both its N and C termini in the 
host cytoplasm and central domain binding the intimin outer-membrane protein 
encoded by the eae gene (Torres et al. 2005). The attachment activates cell-signaling 
pathways, causing alterations in the host cell cytoskeleton and resulting in the 
depolymerization of actin and the loss of microvilli showing as a pedestal structure 
and the eventual death of host cells (Kaper et al. 2004).  
In EHEC strains, a LEE-encoded regulator (Ler) has been required for expression of 
the LEE-encoded proteins (Elliott et al. 2000). The Ler is part of the EPEC and 
EHEC-associated plasmid-endoced regulatory (Per) cascade (Porter et al. 2005). The 
Ler has also been noticed to regulate the expression of additional virulence factors 
not essential for the A/E lesion, which are mediated either by LEE or outside LEE 
(Elliott et al. 2000).  
Of the LEE associated genes, eae and its subtypes encoding the intimate adhesion 
protein (intimin), have offered also a diagnostic and epidemiological value. 
Depending on the E. coli lineage carrying the LEE locus, the size (36 to 111 kb) of 
the LEE regions has varied (Jores et al. 2004), and currently 17 different eae intimin 
types have been found (Blanco et al. 2005). Among the EHEC serotypes 
O157:H7/H¯, O111:H¯, O26:H11/H¯, commonly recovered from outbreaks of HUS 
and hemorrhagic colitis, the most typical intimin subtypes have been eae-?, -?, and  
-? (Blanco et al. 2005). Although the pathogenicity of LEE is supported by the 
presence of the eae gene in important EHEC serogroups like O157, O26, O103, 
O111, and O145 isolated from HUS patients (Karch 2001, Kaper et al. 2004). 
However, LEE-negative serogroups of Stx producing strains have also occurred that 
have been associated with disease, for example also in the O groups O103 (Kaper et 
al. 2004) and O174 (Keskimäki et al. 1997, Paton et al. 2001), thereby complicating 
the pathogenesis. In addition, newly recognized adhesion factors and fimbria 
encoded outside the LEE have been suspected to promote the pathogenicity of 
EHEC (Tschäpe and Fruth 2001, Paton et al. 2001, Kaper et al. 2004, Toma et al. 
2004, Torres et al. 2005), although LEE is still considered to be one of the most 
fundamental adhesion mechanisms. 
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4.2 Plasmid mediated virulence characteristics 
EHEC strains have carried numerous plasmid-mediated determinants like Ehly, 
encoded by EHEC-hlyA (Karch and Bielaszewska 2001, Kim et al. 2001, Beutin et 
al. 2002), the Type II Secretion System (ETP) encoded by etpD (Schmidt et al. 
2001), hemolytic protein (cytolysin A) encoded by clyA (Ludwig et al. 2004), and 
esterase inhibitor-specific metalloprotease encoded by stcE (Lathem et al. 2003). 
However, strains of SF O157:H? alone have been shown to carry a gene cluster (sfp)
specific for the expression of fimbriae (Brunder et al. 2001, Friedrich et al. 2004), 
Instead, unlike other typical EHEC stains, SF O157 isolates have lacked the plasmid 
mediated catalase peroxidase (KatP, katP) and serine protease (EspP, espP) (Karch 
and Bielaszewska 2001). 
4.2.1 Enterohemolysin (Ehly)  
EHEC strains have in common a 60 Mda plasmid (Whittam 1998) that carries four 
open reading frames (ORFs) responsible for the enterohemolytic phenotype (Karch 
et al. 1998). These genes encoding the Ehly protein have been termed EHEC-hlyC,
EHEC-hlyA, EHEC-hlyB, and EHEC-hlyD that are highly related to the genes of the 
E. coli ?-hemolysin, the naming of the genes thus being analogous to the respective 
genes of the E. coli ?-hemolysin operon (Karch et al. 1998). Ehly protein acts as 
pore-forming, repeats in toxin (RTX) cytolysin on eukaryotic cells, lyses 
erythrocytes, and is considered a putative pathogenetic mechanism of EHEC 
bacteria (Beutin et al. 1989, Beutin et al, 1994, Kaper et al. 2004). However, 
mutations of the open reading frames (ORFs) of the EHEC-hly gene have resulted in 
the loss or reduction of the enterohemolytic phenotype (Karch et al. 1998). Among 
EHEC strains, the carriage of EHEC-hlyA and production of Ehly have been typical 
of the O157:H7 strains. Instead, of the SF O157:H? strains, the strains have typically 
possessed the EHEC-hlyA but have not clearly shown enterohemolytic activity 
(Karch and Bielaszewska 2001).
4.2.2 Putative type II secretion system (ETP) 
The type II secretion pathway system has frequently been involved in the transport 
of pathogenicity factors outside the bacterial cell in gram-negative bacteria (Brunder 
et al. 2001, Friedrich et al. 2004). In EHEC plasmids, DNA analysis has lead to the 
finding that the ETP system of EHEC strains includes 13 open reading frames, the 
respective genes called etpC to etpO (Schmidt et al. 2001). However, the total 
function and specificity of the ETP system are not well understood  (Caprioli et al. 
2005). 
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4.2.3 Katalase peroxidase (KatP) 
KatP is a bifunctional, bacterial catalase peroxidase (Schmidt et al. 2001). It 
harbours an aminoterminal signal peptide, suggesting that it is transported through 
the cytoplasmic membrane. KatP has been present mainly in periplasm in wildtype 
E. coli O157 strains but unlike NSF O157 strains, SF O157 isolates have typically 
lacked katP genes (Karch and Bielaszewska 2001, Schmidt et al. 2001).  
4.2.4 Serine protease (EspP)
Unlike other Esp proteins (EspA, EspB, EspD), the secreted serine protease EspP is 
plasmid mediated. The EspP can cleave human coagulation factor V in vitro
(Schmidt et al. 2001) and might be an accessory virulence factor exacerbating 
hemorrhagic colitis (Brunder et al. 1999, Schmidt et al. 2001). For example, sera 
from five of six children suffering from EHEC infections reacted with purified EspP 
protein (Schmidt et al. 2001). However, unlike NSF O157 strains, SF O157 isolates 
have typically lacked espP genes (Karch and Bielaszewska 2001).  
4.2.6 Other chromosomal and plasmidal virulence factors 
Virulence factors of EHEC include, for example, surface structure proteins such as 
endotoxins. In addition, among EHEC bacteria, numerous other virulence factors 
have been characterized  (Prager et al. 2005). In some strains, the production of a 
lymphostatin and EHEC factor for adherence (Efa1) encoded by efa1 (Klapproth et 
al. 2000, Nicholls et al. 2000, Janka et al. 2002) have been detected. In addition, 
novel STEC autoagglutinating adhesin Saa encoded by the virulence plasmid 
pO113, might contribute to pathogenesis (Paton et al. 2001). This pO113 plasmid, 
also known as large hemolysin plasmid, has been isolated from a LEE-negative 
strain O113:H21, which was responsible for outbreak of HUS (Paton et al. 1999). 
Recently, the nucleotide sequence of the pO113 has been determined, showing a 
high degree of similarity with pathogenic transporter regions, for example EspP 
(Leyton et al. 2003). This plasmid also carries a novel type IV pilus biosynthesis 
locus that is required for efficient plasmid transfer (Srimanote et al. 2002). Of other 
virulence factors, a heat stable enterotoxin (EAST) typical of EAEC group has been 
detected among strains of EHEC (Karch et al. 1999b). Moreover, production of a 
new virulence toxin, subtilase (Paton et al. 2004), or cytolysin A (ClyA) (Ludwig et 
al. 2004) might be a contributing factor(s) to the virulence of some EHEC strains or 
the Stx-negative E. coli O157 strains. Furthermore, in strains of SF EHEC O157:H?
a novel plasmidal sfp gene cluster (sfpA, sfpH, sfpC, sfpD, sfpJ and sfpG), which 
mediate mannose-resistant hemagglutination and the expression of fimbriae, has 
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recently been characterized (Brunder et al. 2001). Interestingly, this cluster has taken 
over the plasmidal loci of katP and esp (Brunder et al. 2001, Bettelheim et al. 2002, 
Friedrich et al. 2004). Also, most of the SF O157:H? strains have possessed a 
chromosomal gene cluster encoding a novel type of CDT toxin designated CDT-V, 
which has rarely been found in E. coli O157:H7 (Janka et al. 2003). Among newly 
recognized plasmid pO157 mediated toxins, ToxB belonging to a large clostridial 
toxin family has been characterized. These AB-toxins mediate cell entry, which may 
lead to altered regulation of cell cytoskeleton and eventually diarrhea (Schmidt et al. 
2001). 
4.3.  Transmission of virulence factors and bacterial species 
Genes encoding important virulence factors are often located on mobile genetic 
elements, such as insertion sequences, transposons, gene cassettes, integrons, 
plasmids or bacteriophages and can therefore be transferred horizontally from one 
cell to another (Karch et al. 1999a, 1999b, Brunder and Karch 2000). This 
transposition event is defined as a DNA recombination reaction resulting in 
translocation of a discrete DNA segment such as the insertion sequence or 
transposon from a donor site to target site, that can cause changes in gene expression 
(Brunder and Karch 2000). Furthermore, gene cassettes and integrons allow natural 
cloning and expression of cells, and the exchange of plasmids between bacteria is an 
important source of genomic variation (Brunder and Karch 2000). For example, the 
chromosomally integrated pathogenecity island LEE locus occurrs among strains of 
EPEC and EHEC (Karch 2001, Schmidt and Hensel 2004). Some plasmids are 
associated with phenotypes, such as antibiotic resistance of several bacterial species 
(Dougan et al. 2001). Among EHEC, Stx toxins are encoded by several different 
lambdoid bacteriophages, which can cause lysogenization of various enteric 
bacteria, particularly E. coli and horizontal spread of Shiga toxinogenicity (Unkmeir 
and Schmidt 2000, Tschäpe and Fruth 2001). For example, Stx-producing strains 
have been found among S. dysenteriae type 1, S. sonnei (Strauch et al. 2001), C.
freundii (Schmidt et al. 1993, Tschäpe et al. 1995), and E. cloacae (Paton and Paton 
1996, Herold et al. 2004). In addition, free stx-phage particles have been detected in 
nature, such as in a natural water environment (Muniesa et al. 1999). 
5. Screening for EHEC  
Early diagnosis of EHEC infections in routine microbiological laboratories creates a 
basis for crucial acts, such as treatment of the patient and prevention of additional 
cases of EHEC infection (Karch et al. 1999a). The identification of strains of E. coli
O157 has worldwide been well-covered in routine microbiological laboratories with 
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the use of differentiating media, especially Sorbitol-MacConkey agar (SMAC) 
(March and Ratnam 1986, Paton and Paton 2003), and commercial detection kits 
based on the agglutination and immunological reaction (Table 2). The SMAC plate 
differentiates the NSF isolates of serogroup O157 as colorless colonies compared to 
the other E. coli flora, which typically ferment sorbitol and have a red phenotypic 
appearance. However, some enterobacterial genera or species, such as Proteus,
Providencia, Hafnia, Enterobacter, and E. hermanii, also grow in colorless colonies, 
of which some species share common epitopes with the O157 antigen causing 
crossreactions (March and Ratnam 1986, Lior and Borczyk 1987, Karch et al. 
1999a). In addition, Yersinia enterocolitica O:9 has cross-reacted with human anti-
O157 sera (Chart et al. 1991). An SMAC plate containing inhibitory components, 
such as cefiximide and tellurite (CT-SMAC) for other bacterial species, has also 
been used in the detection of strains of NSF O157. However, this medium has also 
been inhibitory particularly for strains of SF O157 (Karch and Bielaszewska 2001), 
which limits its use. A considerable number of strains within the O157 and non-
O157 serogroups have been sorbitol-fermentative, thus complicating phenotypic 
detection of these pathogens on SMAC. However, rapid agglutination or 
immunomagnetic separation (IMS) tests using the serological capture and detection 
of the most common serogroups of non-O157 strains (O26, O91, O103, O111, 
O128, O145) have been exploited for the detection of these pathogens.  
Based on the vast phenotypic diversity of EHEC bacteria, the most effective 
detection method for detection of all EHEC bacteria has been the detection of the 
Stx production or the investigation of the stx genes of the isolates. As the definition 
of EHEC bacteria is the production of Stx or the related stx genes, several methods 
have been developed for detection of the toxin(s) (Table 2). Of these methods, 
enzyme-immunoassays (EIA-assays) detect the presence of Stx1 and/or Stx2 
toxin(s) in bacterial cultures or stool. Most EIA tests are based on the sandwich-
method, where immobilized monoclonal or polyclonal antibodies have been used as 
ligands for Stx molecules. The bound Stx toxin and antibody-enzyme-conjugate of 
the kit forms a visible color reaction, thus indicating the presence of the Stx toxin in 
the sample. In addition, reversed passive latex agglutination (RPLA) tests detect 
Stx1 and/or Stx2 in bacterial cultures. In the RPLA, the presence of Stx(s) is 
detected with anti-Stx bound to latex particles. During incubation, the presence of 
Stx(s) in the sample is indicated by agglutination of the Stx toxin and the latex 
bound anti-Stx molecules in the walls of the sample dwell in a microtiter plate. 
However, other bacterial genera, such as Campylobacter, Citrobacter,
Pseudomonas, and Edwardsiella, have also been observed to produce Stx, which 
might produce bias towards false positive reactions in Stx testing and search for 
EHEC bacteria (Beutin et al. 1996a, Kehl et al. 1997, MacKenzie et al. 1998, Pickett 
2000). Thus, the isolation of the Stx-producing strain is very crucial for 
microbiological confirmation of the causative strain’s species and pathogroup.  
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In specialized laboratories, molecular genetic methods like polymerase chain 
reaction (PCR) and hybridization methods have been of great value in detection of 
the stx genes of EHEC bacteria and the subsequent isolation of the EHEC strain. 
Currently, many of these methods have also become commercially available. Of the 
detection methods, the PCR enables the testing of bacterial culture or direct patient 
sample, such as stool, for the virulence genes to be searched. However, generally, 
the stool cultures or pure bacterial cultures are preferred because stool typically 
contains inhibitory substances for the PCR-reaction, lowering the specificity and 
sensitivity of the test (Paton and Paton 2003). Also, in the detection of EHEC, 
timelapse between the sampling of the specimen and onset of EHEC infection has 
affected the rates of recovery and overall detection of EHEC isolates. Human fecal 
specimens collected two days after the onset of symptoms have had an isolation rate 
of 100% for E. coli O157, but the rate has decreased to 33% for specimens collected 
after seven days (Thomson-Carter 2001). For the recovery of E. coli O157, 
especially, enrichment procedures have been used succesfully, in particular with the 
combination of the IMS technique (Karch et al. 1999a, Thomson-Carter 2001).  
Table 2. Methods for the detection of EHEC bacteria. 
Diagnostic Principle Test method 
Phenotypic methods 
Detection of E. coli O26, O91, O111, O103, 
O111, O145, O157 antigens in bacterial culture 
Latex agglutination, 
immunomagnetic separation (IMS) 
Selective isolation of E. coli O157 bacteria 
based on color reaction on agar plate 
Chromogenic agars 
Detection of enterohemolysin production of 
bacterial culture on agar plate 
Enterohemolysin agar 
Screening for Stx toxin or O157 antigen in 
bacterial culture or stool 
Enzyme immuno-assays (EIA) 
Screening and separate detection of Stx1 and 
Stx2 toxins in bacterial culture or stool  
Reverse passive latex agglutination 
(RPLA)
Genotypic methods  
Detection of genes encoding Stx, O specific 
regions or accessory virulence factors in 
bacterial culture or stool 
PCR, PCR combined with 
restriction fragment length 
polymorphism (PCR-RFLP),  
PCR combined with hybridization, 
colony hybridization, 
immunoblotting 
Data based on Karch et al. 1999a, Perelle et al. 2004, Beutin et al. 2005, Feng et al. 
2005, Prager et al. 2005, and an additional Internet search using the following search 
terms: diagnostics, sltec, stec, ehec, or vtec. 
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6. Subtyping of EHEC 
In the epidemiological surveillance of human infectious diseases, the detailed 
pheno- and genotypic characterization of the causative human isolate allows targeted 
investigations not only between human infections, such as person-to-person 
contacts, but also between human and non-human sources like contaminated food, 
cattle, or the environment (Karch et al. 1999a, Lahti et al. 2002, Heinikainen et al. 
2004). In the differentiation of EHEC, the methods used must have high typeability, 
reproducibility, and high discriminatory power. In addition, interlaboratory 
harmonization of the methods used has been preferable. The cornerstones in both the 
national and international epidemiological study of EHEC O157 and non-O157 
infections has been characterization of the isolates for determinants, such as the O:H 
serotype, phage type, stx gene possession or their variants, and restriction profile 
type in pulsed-field gel electrophoresis (PFGE). In addition, simultaneous molecular 
biological detection of several characteristics, such as stx, eae, ehly, saa, have 
enabled fast early phase epidemiological comparison of EHEC strains (Paton and 
Paton 2002). 
6.1 Phenotypic methods 
Among EHEC bacteria, phenotypic characteristics, such as sorbitol-fermentation 
ability, ?-glucuronidase activity, production of enterohemolysin or Stx of the isolate, 
have been crucial determinants. Subsequent serotyping of the EHEC strains and 
phage typing of the EHEC O157 isolates have allowed fast epidemiological, 
internationally comparable, first step phenotypic categorization of these organisms. 
Moreover, antimicrobial susceptibility testing and the resulting resistance patterns of 
the EHEC O157 and non-O157 strains have been offered informative data as an 
epidemiological marker of these isolates. 
Serotyping offers a valuable means for classification of the E. coli strains forming a 
basis for epidemiologic analysis. Since the first evidence that certain serological 
types of E. coli were associated with epidemics of enteritis during 1945–1950 and 
following pioneering work (Kauffmann 1947, Ørskov and Ørskov 1984), it was 
established that E. coli express three principal antigens: O, K, and H antigens. 
Identification of these E. coli surface structures relate to components of somatic, 
lipopolysaccharide (LPS)-associated O-polysaccharide (O-antigen), capsular 
polysaccharide (K), and flagellar (H)-antigen. Especially the O grouping can be 
performed in many clinical laboratories, while the H antigen can be determined in a 
limited number of laboratories, and the 80 types of K antigens (Wain et al. 2001) to 
an even less extent (Scheutz et al. 2004).  
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Currently, 176 distinct E. coli O antisera differentiating E. coli O groups are 
available (Scheutz et al. 2004, Olesen et al. 2005, www.ssi.dk). The O antigen is the 
highly polymorphic outer part of LPS, which comprises repeats of an O unit of 
generally two to seven sugars. Each strain express only a particular O-antigen form 
(Thomson-Carter 2001, Feng et al. 2005) but the surface structure of living E. coli
bacterium might form unspecific crossreactions with different O antisera. However, 
boiling the bacteria eliminates other surface antigens leaving O chains intact, thus 
allowing final determination and confirmation of the O group. For this reason, 
international standard procedure for O-typing is requesting always boiling and 
agglutination test in microtiter plates as well as dilution of respective antisera. 
However, some commercial O antisera for E. coli O-grouping are also available, 
which do not require the use of boiled bacterial cultures for determination of the 
final O group. In determining of the O group, if no full panel of the O antisera is 
available in the typing laboratory, E. coli strains not reacting with any sera used 
have been designated O Nontypeable (ONT). In addition, strains typically having a 
rough phenotypic appearance and lacking the O antigen, and crossreacting with the 
panel of the sera are interpreted as O Rough. Two main differentiating EHEC O 
group categories, O157 and non-O157, have been designated among EHEC. Among 
the non-O157 strains, over 450 O:H types have been reported (Blanco et al. 2004), 
with over 1,000 reports of isolations of non-O157 strains (Blanco et al. 2004, 
www.microbionet.com.au). 
For phenotypic determination of the flagellar H antigen, active motility of the strain 
is required. The motility is provided by the rotating flagellum which projects beyond 
the surface of E. coli cell (Wang et al. 2003). Flagellin is the protein subunit of the 
flagellum that carries H-antigenic specificity (Wang et al. 2003). For E. coli, 56 
flagellar antigen groups (Ørskov and Ørskov 1984) that can be identified with H-
specific antisera (Ratiner 1991) have been described. The mechanism of motility in 
E. coli is complex, under intricate regulatory control and affected by environmental 
factors (Feng et al. 1996, Pallen et al. 2005). However, the presence of flagella is not 
indicative that these strains are motile (Feng et al 1996). The nonmotility (NM) of 
the strains might be due to carriage cryptic flagellum genes (Prager et al. 2003, 
Coimbra et al. 2000, Machado et al. 2000, Ren et al. 2005) or they could be 
defective in other mechanisms of flagellum assembly or motility (Feng et al. 1996). 
Nonmotile strains are usually induced extensively for motility before being 
designated HNM. Of EHEC strains, both motile and nonmotile O:H serotypes have 
been found.  
Phage typing has been another important phenotypic method in the differentation of 
pathogenic enteric bacteria. In phage typing, bacterial viruses (i.e. bacteriophages) 
are exploited to initiate an infection on a layer of bacterial cells. A zone of lysis may 
occur that results in a clear area in the lawn of growing host cells. Being based on 
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variable capabilities of different bacteriophages to lyse bacterial isolates, phage 
typing has enabled the rapid differentation between isolates during outbreaks and 
epidemiological surveillance. For EHEC O157, a standardized phage-typing scheme 
using 16 different phages was developed in Canada in 1987 (Ahmed et al. 1987). At 
present, more than 80 EHEC O157 phage types (PTs) can be recognized and 
compared internationally (Willshaw et al. 1997). Of the EHEC non-O157 strains, 
phage typing has preliminarily been used only for strains of O group O103 (Prager 
et al. 2002). 
Enterohemolysin production has been exploited as a blood-based detection method 
in characterization of EHEC strains. The ability of certain E. coli strains to lyse 
erythrocytes was first described by Kayser in 1903 (Kayser 1903, Schmidt and Benz 
2003). This ability was termed hemolysis and the proteins involved were termed 
hemolysins. One of the best characterized E. coli hemolysin is ?-hemolysin 
producing large clear zones of hemolysis after 3-6 h of incubation at +37°C 
(Schmidt and Benz 2003). However, in 1988, Beutin et al. (1988) found a new type 
of hemolysin, Ehly, which was produced by some strains of EPEC. Soon, they 
noticed that there was a nearly 90% association also between certain strains of 
EHEC and production of Ehly (Beutin et al. 1989). In contrast to ?-hemolysin, 
which produces hemolytic reactions after a few hours, enterohemolytic appearance 
is observed only after overnight incubation on blood plates containing washed sheep 
erythrocytes (Beutin et al. 1989). Currently, commercial agar plates detecting the 
Ehly production are also available (Table 2). This phenotypic appearance has been 
helpful not only in colony search of EHEC isolates in stool culture but also in 
epidemiological comparison.  
6.2 Genotypic methods 
Genotypic identification methods that utilize molecular biology-based techniques 
usually offer several potential advantages over conventional phenotypic methods. 
PCR or hybridization methods like colony hybridization are very suitable for both 
screening purposes and the isolation of the strains possessing the target genes. 
However, although PCR methods offer a distinct advantage for the detection of 
fastidious and noncultivable organisms (Vora et al. 2004), in clinical microbiology, 
isolation of the causative strain should not be neglected, as epidemiological research 
and microbiological confirmation requires the isolation of the pathogen.   
 PCR method was described first by Saiki et al. (1985), and Mullis and Faloona 
(1987). Soon, a first PCR assay to detect stx genes in E. coli was executed (Pollard 
et al. 1990), and today PCR has become a versatile, rapid, and sensitive molecular 
genetic typing method of pathogenic microbes. During the procedure, a known DNA 
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sequence is amplified by the use of a unique primer pair hybridized to the 
complementery target DNA-sequence. Polymerase enzyme and deoxynucleotide-
triphospahate (dNTP) enable the exponential amplification of the target DNA in 
specific reaction conditions and stringent temperature providing a high sequence-
specificity. Theoretically, each PCR-cycle doubles the amount of the target DNA, 
resulting in a billion-fold amplification of the target DNA.  
PCR methods have been used for both overall detection of stx and differentiatiation 
of stx1 and stx2. Particularly the PCR methods combined with restriction fragment 
length polymorphism analysis (PCR-RFLP) allow further characterization of the stx1
and stx2 variants, which improves epidemiological discrimination of the strains and 
allows international comparison of subtypes of stx genes (Bastian et al. 1998). In 
addition, the subtyping of stx might have pathogenetic importance (Friedrich et al. 
2002). PCR-related applications like real-time PCR (i.e. quantitive PCR), or 
multiplex PCRs detecting several genes simultaneously have been widely used 
recently.
For rapid detection of EHEC non-O157 from clinical samples, PCR has proven to be 
of widely used method for the detection of stx genes (Blanco et al. 2004). In 
addition, in epidemiological typing of EHEC non-O157, recently described PCR 
methods have enabled the more efficient and rapid detection of the most common O 
groups (Perelle et al. 2004, Beutin et al. 2005, Feng et al. 2005). Furthermore, the 
flagellar fliC genotyping by PCR-RFLP has enabled the detection of the certain H-
antigen gene possession (Prager et al. 2003). PCR has enabled also the detection of 
genes determining metabolic characteristics, such as uidA, or virulence 
determinants, such as EHEC-hlyA or eae. With the use of multiplex-PCR, for 
example, detection of five different genes occurring in EHEC (stx1, stx2, eae, ehly,
saa) is possible (Paton and Paton 2002). 
Pulsed-field gel electrophoresis is one of the most important discriminatory 
methods in genetic characterization of bacterial strains and commonly used 
approach to assess the relatedness of clinical isolates (Goering 2000). PFGE is 
recommended worldwide as a gold standard molecular typing method, that provides 
a chromosomal overview scanning >90% of the chromosome (i.e. the sum of the 
restriction fragment sizes). The use of restriction enzyme(s) enables detection of 
chromosomal differences between isolates, and the macro-restriction patterns of 
large DNA fragments reflect the distances between restriction sites around the 
chromosome (Goering 2000, Tenover et al. 1995). Although minor genetic changes 
may go undetected (Goering 2000), PFGE has enabled discriminative determination 
in the molecular comparison of EHEC strains independent of the serotype, and in the 
investigation of EHEC O157 and non-O157 infections such as O26, O103, O111, 
and O118, PFGE has been widely used (Thomson-Carter 2001).  
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Isolates with indistinguishable macrorestriction patterns are generally considered to 
be associated with each other. Currently, however, no specific interpretative rules 
exist for EHEC PFGE data, only general guidelines for certain bacterial species 
(Thomson-Carter 2001). For example, in clonal analyses and in the long-term 
epidemiological surveillance, strains with up to four-band difference or with over 
75% similarity indexes of PFGE dendrograms, have been considered related if other 
geno- and phenotypic markers have also supported the relatedness (Tenover et al. 
1995, Bielaszewska et al. 2000, Liesegang et al. 2000, Beutin et al. 2002, Prager et 
al. 2002, Duffy et al. 2005). Minor variation (1-2 fragment(s) absent or present) in 
macrorestriction patterns has been observed among strains of EHEC, including 
isolates considered to be epidemiologically linked, although previously, certain 
fragment differences have been shown to be insignificant (Thomson-Carter 2001). 
In addition, the effect of chromosome evolution on EHEC macrorestriction patterns 
obtained under experimental conditions, has been suspected to be minimal 
(Thomson-Carter 2001). 
Standardization of the PFGE protocols and electronic submission of gel images have 
created a genetic database where macrorestriction patterns for unknown isolates 
could be compared for epidemiological purposes, outbreak investigation and 
definition of clonal relationships. These harmonization acts have allowed very exact 
national epidemiological comparison of human and non-human isolates of EHEC in 
Finland (Rantala et al. 2000), and the USA (Swaminathan et al. 2001, PulseNet 
2002) and international comparison of EHEC human isolates within European 
countries (PulseNet 2002, Fisher and Threlfall 2005, www.hpa.org.uk/inter/enter-
net_menu.htm).  
Other genotypic methods such as multilocus enzyme electrophoresis (MLE), 
plasmid analysis, DNA sequencing, and multilocuc sequence typing (MLST), have 
also been used, although MLST has not been succesful in discrimination of E. coli
O157:H7 isolates (Noller et al. 2003). However, the use of the variable-number 
tandem repeats (VNTRs) technique has been exploited in clonality research of E.
coli O157:H7 bacteria. In particular, multi-locus VNTR analysis (MLVA) that 
examines multiple VNTR loci has been utilized along with PFGE in epidemiological 
comparisons and to distinguish outbreak and sporadic E. coli O157:H7 isolates 
(Noller et al. 2003, Lindstedt et al. 2004). Moreover, microarray-based pathogen 
detection targeting eae, stx1, stx2, and fliC has recently been developed (Vora et al. 
2004).  
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AIMS OF THE STUDY 
The aims of this study were: 
- To set up pheno- and genotypic methods to gain epidemiological 
knowledge on the characteristics of human EHEC O157 and non-O157 
strains isolated in Finland. 
- To study the potential association of certain characteristics of human EHEC 
O157 and non-O157 strains with a clinical picture of a patient. 
- To compare the molecular and phenotypic profiles of nonmotile SF O157 
human strains isolated in Finland to those occurring in Germany.  
- To help in epidemiological surveillance and trace back human EHEC O157 
and non-O157 infections. 
- To determine the geographical prevalence of EHEC in Finland and explore 
the putative sources of human EHEC infections by in-depth interviews of 
the infected people.
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MATERIALS AND METHODS 
1. Bacterial strains and patients (I–V) 
1.1 EHEC strains isolated from patients (I–V)
All EHEC strains of E. coli O157 (n=127) and non-O157 (n=73) isolated from 
Finnish subjects (n=200) with EHEC infection from 1990 through 2002 in Finland 
were studied (Table 3). Also, three additional EHEC non-O157 strains isolated from 
the patients with double infection, and three O157 strains being negative for stx were 
analysed. The strains originated from E. coli cultures or primary stool cultures sent 
from the clinical hospital laboratories to the Enteric Bacteria Laboratory (EBL) of 
the National Public Health Institute (KTL) for microbiological identification and 
verification of the presence of EHEC bacteria.  
Table 3.  Number of subjects and E. coli O157 and non-O157 strains isolated during 
               1990–2002 and used in this study.  
1.2 Reference strains (I–V)
Reference strains used at EBL originated from the strain collections of the American 
Type Culture Collection (ATCC, USA), the Belgium Coordinated Collections of 
Microorganisms (BCCM, University of Ghent, Belgium), the National Veterinary 
and Food Research Institute (EELA, Helsinki, Finland), the Laboratory of Enteric 
Pathogens, Health Protection Agency (HPA, London, England), the International 
Escherichia and Klebsiella Centre (WHO), Statens Serum Institute (SSI, Denmark), 
and the Robert Koch Institute (RKI, Berlin, Germany) (Table 4). In addition, for O 
grouping, O-specific strains (n=40) originating from SSI or EBL were used.  
       Isolates of serogroup     Time period
Study Subjects Isolates O157 Non-O157      (mo / year) 
I 105 105 105 0 1/1990–12/1999 
II 55 56 0 56 1/1990–  8/2000 
III 170 173 111 62 1/1990–12/2000 
IV 99 99 52 47 1/1998–12/2002 
V 9 9 9 0 1/1997–  3/2002 
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Table 4. Reference strains used as positive or negative controls. 
Species and Characteristic   Strain reference Study 
Strain No. needed       and origin
E. coli
RH 1484 Negative control 25922 ATCC I-V 
RH 4270 stx1, stx2, eae, ehlyA 43895  ATCC I-V 
RH 4872 stx2d-Ount LMG 18459  BCCM I, III, IV 
RH 4827 O157:H7 PFGE pattern G5244 EELA I, II, IV, V 
RH 1741 Phage type PT2 TS2 HPA I, III, IV, V 
RH 1760 Phage type PT8 TS4 HPA I, III, IV, V 
RH 1743 Phage type PT14 TS8 HPA I, III, IV, V 
RH 1744 Phage type PT32 TS14 HPA I, III, IV, V 
RH 1745 Phage type PT49 TS32 HPA I, III, IV, V 
RH 1746 Phage type PT54 TS54 HPA I, III, IV, V 
IH 57022 H-antigen H21 IH 57022 EBL I-V 
IH 57105 H-antigen H161 IH 57105 EBL I-V 
IH 57074 H-antigen H491 IH 57074 EBL I-V 
IH 53472 Enterohemolysis CB 4120 RKI II, III, V 
IH 53471 Non-hemolysis KK7/1 RKI II, III, V 
IH 53470 ?-Hemolysis U4/41 RKI II, III, V 
RH 6015 eae-? RD 267 EELA V 
RH 6017 eae-? RD 396 EELA V 
RH 6019 eae-? RD 609 EELA V 
RH 6021 eae-? C 622 EELA V 
Salmonella Braenderup   
RH 6184 International PFGE control H9812 SSI V 
1 Verified by SSI. 
1.3 Data collection of the patients with EHEC infection (I–V)
The data on the age, gender, symptoms, a recent travel abroad, and home locality of 
the subject were collected on a special form accompanying the isolate or were asked 
by telephone from the hospital. In addition, during 1998–2002, a subset of patients 
(n=68) was interviewed in-depth by telephone by a trained person at KTL. 
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Interviewees were asked about consumption of cooked, undercooked, or 
unpasteurized food items, contact with cattle farm or other animals, contact with 
persons having diarrhea, or environmental exposure.  
2. Investigation of the stool- and pure E. coli cultures (I–V)  
The presence of EHEC bacteria in primary stool cultures or pure cultures was 
investigated by PCR detecting the stx1 and stx2 genes (Table 5). In addition, the 
possession of eaeA was studied (Heuvelink et al. 1995, Keskimäki et al. 1996). The 
primers for the stx1 and stx2 genes were according to Olsvik and Strockbine 1993, 
Jackson et al. 1987a and Jackson et al. 1987b. The protocol was executed as 
previously described (Olsvik and Strockbine 1993, Keskimäki et al. 1998) except 
that the PCRs were carried out separately and with minor modifications (Eklund et 
al. 2001). A loopful of the bacterial growth on agar plates suspended in 500 ?l of 
sterile water was boiled for 10 minutes, and the amount of template was 1.5 ?l. The 
PCR run of stx1 was executed as described (Olsvik and Strockbine 1993) except that 
the amplification steps were repeated 35 times. All PCR runs included positive (RH 
4270) and negative (RH 1484) control strains. PCR reactions were also internally 
controlled with one colony of the positive control strain spiked into the suspensions 
of the primary cultures to reveal the possible inhibitory factors for the PCR reaction. 
All PCR products were electrophoresed through 1% agarose gel (SeaKem ME, FCM 
BioProducts, Mich.), the gel was stained with ethidiumbromide, and visualized and 
photographed by AlphaImager system (Alpha Innotech, CA) under UV 
transillumination. The amplified fragments were identified according to their 
specific size. After confirmation of the carriage of the stx gene(s), the specific 
colony was subcultured as pure culture and stored in skim milk tubes at -70°C for 
further use.  
3. Identification of the EHEC isolates (I–V) 
All isolates were identified biochemically as E. coli species by API 20E 
(BioMérieux SA, Marcy l’Etoile, France). In addition, sorbitol fermentation of the 
isolates was detected on SMAC agar plates and in tubes containing 0.5% sorbitol 
after overnight incubation at 37°C (Wells et al. 1983). The ?-glucuronidase (PGUA) 
activity of the isolates was investigated with Rosco diagnostic tablets (A/S Rosco, 
Taastrup, Denmark) after four hours to overnight incubation at 37°C. 
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4. O:H serotyping (I–V) 
The isolates were O grouped as previously described (Ørskov and Ørskov 1984, 
Siitonen 1992). The agglutination of the heated bacterial suspension with O-specific 
antisera indicated the O type. The strains giving clumping with 4% saline indicated 
the loss of the O antigen, and were defined as O Rough. In addition, the O157 
antigen was tested with the E. coli O157 antigen kit (Oxoid, Basingstoke, England). 
Of the specific O-sera used, 35 (O1, O2, O4, O6, O7, O8, O9, O11, O15, O16, O18, 
O22, O25, O26, O44, O50, O55, O75, O77, O83, O85, O86, O91, O100, O111, 
O112, O114, O119, O124, O125, O126, O127, O128, O142, O157) originated from 
KTL and five from SSI (O5, O103, O121, O145, O174). The strains nontypeable 
with the sera available at EBL were sent to SSI for further typing. The H type of the 
isolates was indicated by the agglutination of the bacterial suspension of motile 
isolates with specific H antisera detecting all known flagellar antigens. Strains, 
which did not move through a semisolid agar tube after cultivation of five days, 
were indicated as nonmotile (HNM or H¯) (Ratiner 1991). The H antisera were 
obtained from Dr. Yuli Ratiner, the Mechnikov Research Institute for Vaccines and 
Sera, Russia. 
5. Phage typing of O157 strains (I, III–V) 
The bacteriophages specific for E. coli O157 phage typing were kindly provided as 
100 x Routine Test Dilutions (RTDs) from HPA. The bacterial layer grown on 
double strength nutrient agar plates were subsequently exposed to the phages using 
the scheme originally described by Ahmed et al. (1987) and extended by Khakhria et 
al. (1990). The results were interpreted according to a phage type list that reveals 66 
confirmed and 14 provisional phage types. A strain that reacted with the typing 
phages, but did not conform to a defined phage-typing pattern, was defined as 
Reacts but Does Not Conform (RDNC). The result of a RDNC strain was confirmed 
by phage typing five additional colonies of the strain.  
6. Detection of Shiga toxin (Stx) production (III, V) 
The production of Stx1 and Stx2 toxin of the isolates were determined by a 
commercial reversed passive latex agglutination (VTEC-RPLA) test kit (Denka 
Seiken Co, Ltd., Tokyo, Japan). The bacterial cells were grown shaken in Casamino 
Acids-Yeast extract broth overnight at +37°C, lysed with polymyxin (5000 U/ml) 
(Beutin et al. 1996b) during 1 hour incubation in shaking at +37°C, and centrifuged 
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for 30 min at 3,000 rpm (BiofugeA instrument, Heraeus, Sepatech, West Germany). 
The titer of the supernatant was determined according to the manufacturer’s 
instructions. The quantification of Stx production was detected up to a dilution of 
1:128. 
7. Detection of enterohemolytic (Ehly) activity (II, III, V) 
The ability of the isolates to produce enterohemolysin was detected on tryptose
blood agar plates (Difco Laboratories, Detroit, Mich.) supplemented with 10 mM 
CaCl2 and 5% defibrinated sheep blood cells, and washed three times with 
phosphate buffered saline, pH 7.2 (Beutin et al. 1989). The hemolytic reactions of 
the colonies growing on the plates were investigated after three hours (hemolysis 
around the colonies indicated production of ?-hemolysin, negative reaction indicated 
production of enterohemolysin or indicated nonhemolysis), and after overnight 
incubations at 37°C (positive reaction indicated production of enterohemolysin and 
negative reaction indicated nonhemolysis).  
8. Antimicrobial susceptibility testing (II) 
The susceptibility of the isolates for antimicrobial agents were tested by the agar 
diffusion method (National Committee for Clinical Microbiology Standards, 1997) 
on Iso-Sensitest agar (Oxoid, Hampshire, England) for the following 12 agents 
(Oxoid, Hampshire; England): ampicillin, chloramphenicol, streptomycin, 
sulfonamide, tetracycline, ciprofloxacin, trimethoprim, gentamicin, nalidixic acid, 
cefotaxime, mecillinam, and imipenem. 
9. Pulsed-field gel electrophoresis (PFGE) (I, II, IV, V) 
For studies I, II, and IV, bacterial growth of a pure isolate on nutrient agar was 
suspended in TEN-buffer (0.1 M Tris-HCl, 0.15 M NaCl, 0.1 M EDTA, pH 7.5) to 
obtain an absorbance of 0.280-0.310 at 600 nm (UV/VIS Spectrophotometer 
Lambda Bio 10, Perkin Elmer, Überlingen, Germany). A sample plug containing 
equally (500 ?l) bacterial suspension and 1.8% of low-melting-point agarose (InCert 
agarose; FMC BioProducts, Rockland, Maine) was digested overnight with 0.18 
mg/ml of proteinase K (Boehringer Mannheim, Indianapolis, USA) at 50°C in 3 ml 
of ES-buffer (0.5 M EDTA, 1% N-lauroylsarcosine). The plugs were washed as 
previously described (Keskimäki et al. 1998), digested with 10 U of XbaI restriction 
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enzyme (New England Biolabs Inc., Mass., USA) (Table 7) and were 
electrophoresed through 1% SeaKem Gold agar (Cambrex Bio Science Rockland 
Inc., Rockland, ME, USA) using nationally standardized parameters: 5 to 40 s, 21 h, 
6 V/cm, 120°, 14°C, and including the internal reference strain RH 4827 (Rantala et 
al. 2000). After staining in ethidiumbromide, the gel was documented by 
AlphaImager System (Alpha Innotech Corporation, CA., USA) and analysed by 
BioNumerics (versions 1.01, 2.0 or 3.0 software, Applied Maths bvba, Belgium). 
One fragment difference was defined as significant. The O157 PFGE types were 
coded from 1.1 to 1.76. The PFGE types the human non-O157 strains were coded 
according to the O group (for example O26a, O26b etc.). In addition, for study V, an 
internationally standardized PFGE method was used (PulseNet 2002). 
10. PCR-restriction fragment length polymorphism (RFLP) (I, III–V) 
Possession of the stx genes and their variants (stx1, stx2, stx2c) were detected by PCR-
RFLP according to Bastian et al. 1998 and Lin et al. 1993. In addition, carriages of 
stx2d-Ount and stx2d-OX3a were detected according to Pierard et al. 1998 (Table 5, Table 
6). The genes were investigated with minor modifications (Eklund et al. 2002). A 
loopful of bacterial growth on the SMAC agar plates was suspended in 500 ?l of 
sterile water, boiled for 10 min, and centrifuged at 10 000 rpm for 15 sec. Of the 
suspensions, 1 ?l was used as a template, and AmpliTaq Gold (Perkin Elmer, Roche 
Molecular Systems, Inc., Branchburg, N. J.) was used as a polymerase. The cycling 
steps of a PCR run were executed as published, except the final elongation step was 
10 in at 72°C. Strains RH 4270, RH 4872 were used as positive control strains and 
strain RH 1484 was used as a negative control strain. The amplified DNA was 
analysed by gel electrophoresis through a 1% gel (SeaKem ME; FCM BioProducts; 
Mich, USA) and photographed by AlphaImager system (Alpha Innotech 
Corporation, CA., USA) under UV transillumination after staining with 
ethidiumbromide. The PCR products were restricted with 20 U of the restriction 
endonucleases HincII and AccI (Lin et al. 1993, Bastian et al. 1998) and PvuII and 
HaeIII (Pierard et al. 1998) (Table 7). The restricted products were analysed by gel 
electrophoresis by using 2% agarose gel (SeaKem ME agarose, BioWhittaker 
Molecular Applications, Rockland, USA), and photographed as mentioned above. 
11. Intimin typing (V) 
The intimin typing of the eae-?, eae-?, eae-?, eae-? genes was executed by 
multiplex-PCR as described earlier (Reid et al. 1999, Zhang et al. 2002) (Table 5, 
Table 6), except that the common reverse primer eaeP2 was replaced by the primer 
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SK2 (Karch et al. 1993). In addition, the eae-allele specific forward primer EaeF2 of 
this study was complementary to the reverse primer eaeP2 published by Reid et al. 
1999. In addition, bacterial suspensions in 500 μl of sterile water were boiled for 10 
minutes and centrifuged briefly. For the amplification, a 1.5 μl sample was added in 
50 μl reaction mixture (Table 6), and the PCR amplification (Peltier Thermal Cycler, 
PTC 200, MJ Research, Mass., USA) was executed. The amplified products were 
electrophoresed through 1.2% agarose gel (SeaKem ME agarose, BioWhittaker 
Molecular Applications, Rockland, USA), and stained with ethidium bromide.  
12. Additional methods  (V) 
For the nine SF E.coli O157:H¯ strains, a carriage of stx1, stx2, stx2c, eae-?, eae-?,
eae-?, eae-?, efa1, cdt-V A, cdt-V B, cdt-V C, EHEC-hlyA, etpD, katP, espP and sfpA
were determined by PCR and carriage of fliC by PCR-RFLP (Table 5) at the 
Institute of Hygiene and the National Consulting Laboratory on Hemolytic Uremic 
Syndrome, University Hospital Münster, Münster, Germany. In addition, the 
production of CDT toxin was investigated there, with the use of Chinese hamster 
ovary (CHO) cell assay as previously described (Janka et al. 2003, Bielaszewska et 
al. 2004).  
13. Statistical methods (II, III, IV) 
Epi-Info 6 software (Dean et al. 1994) were used for statistical analyzes. In addition, 
Epi-Info 2000 version 1.12 was used for Fisher’s exact two-tailed test to determine 
statistical significance. P<0.05 indicated statistical significance. 
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Table 7. Restriction enzymes used at EBL. 
Method           Enzyme1         Recognition site                 Study 
PCR-RFLP HincII 5’…GTY-RAC…3’ I, III, IV 
  3’…CAR-YTG…5’ 
AccI 5’…GT-MKAC…3’ I, III, IV 
  3’…CAKM-TG…5’ 
HaeIII 5’…GG-CC…3’ I, III, IV 
  3’…CC-GG…5’ 
PvuII 5’…CAG-CTG…3’ I, III, IV 
  3’…GTC-GAC…5’ 
PFGE XbaI 5’…T-CTAGA…3’ I, II, IV, V 
  3’…AGATC-T…5’  
1 New England Biolabs Inc., Mass., USA. 
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RESULTS
1. Occurrence of EHEC infections (I – V) 
During 1990–2002, EHEC infections were detected in 200 patients. In addition, a 
double infection caused by two different strains occurred in three patients. Also, stx
negative strains belonging to the typical EHEC O group O157 caused three 
infections. Of the 200 EHEC infections, strains of O157 caused 127 (64%), and in 
84% of the cases, the infection was indigenously acquired. The remaining 73 (36%) 
infections were caused by strains of EHEC non-O157, also most (78%) being of 
domestic origin. Of all the infections, the majority (187 cases; 94%) occurred after 
1996 with the following findings: 61 cases in 1997, 43 in 1998, 36 in 1999, 17 in 
2000, 15 in 2001, and 15 in 2002. In addition, during the study period were detected 
24 stool samples or mixed cultures being Stx positive in EIA test in clinical hospital 
laboratories (National Public Health Institute, EBL). However, the respective 
cultures of these samples lacked stx genes, did not show detectable Stx production in 
the RPLA test and EHEC isolate could not be found. These cases were excluded 
from further analysis for this thesis.  
2. Demographic data of the patients (I - V) 
The median age of the 200 patients was 9.5 years (range 0.2 to 85.3 years). Most 
(35%) of these patients belonged to the age group of 1 to 5 years (Figure 3). About 
half (n=101) of all patients were males. 
Figure 3. Age distribution (years) of all patients with EHEC infection and  
               serogroups of the infecting strains. 
0 10 20 30 40 50 60 70 80
>65 yrs (n=9)
 56-65 yrs (n=6)
 26-55 yrs (n=40)
 16-25 yrs (n=25)
 6-15 yrs (n=46)
 1-5 yrs (n=69)
 <1 yrs (n=5)
Number of cases
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non-O157 cases (n=73)
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3. Pheno- and genotypic characteristics of strains (I - V) 
3.1 O157 strains (I, III–V)
In all, 127 EHEC O157 strains were isolated the study period 1990–2002. Of these, 
110 isolates (87%) carried stx2 only, and 17 isolates possessed both stx1 and stx2.
None of the strains carried the stx1 only. Of all O157 strains, the majority (114 
strains; 90%) were sorbitol-and ?-glucuronidase negative, and expressed the H7 
antigen. All these strains produced Stx1 and/or Stx2 with titers ranging from 1:2 to 
1:128, and were enterohemolytic. In addition 13 SF, ?-glucuronidase positive, 
EHEC O157:H? strains were detected.  
Of all EHEC O157 strains isolated from 105 Finnish patients during 1990–1999, the 
main phage types of the strains were PT2 (56%), PT49 (11%), PT4 (10%) and PT88 
(6%). Among the 105 infections, 93 O157 strains of domestic origin were detected, 
which were distributed into 24 PFGE types. The remaining 12 strains were 
associated with a recent trip abroad, which were distributed into 10 PFGE types. Of 
the PFGE types of foreign origin, two occurred also indigenously. The main 
PT/PFGE combination was PT2/1.1 representing 46% followed by PT49/1.12 (4%) 
and PT4/1.47 (4%). Of all 32 PFGE types, 30 (94%) associated only with a certain 
PT. The remaining two PFGE types (1.1 and 1.3) included PTs 2, 14, and 2, 50, 
RDNC, respectively.
By PCR-RFLP, 70% of the 105 strains possessed stx2 with stx2c. Most (71/74 
strains) of the strains carrying both of these two genes were of domestic origin. The 
strains possessing stx2 only (21 strains) belonged to six PTs (PT2, 4, 14, 50, 88, and 
RDNC) and 12 PFGE subtypes. Of the stx2 positive strains 18 (86%) were of 
domestic origin, only three strains (PT4/1.47) being linked to a cruise between 
Finland and Sweden. The strains carrying stx2c only were all of foreign origin 
(Turkey [PT8/1.9], Spain [RDNC 3/1.11], and Greece [RDNC3/1.59]. The five 
strains positive for stx1 and stx2c associated mostly with a recent trip to Spain 
(PT8/1.52), Turkey (PT8/1.29), and the Czech Republic (PT8/1.30).  
Of the domestically acquired E. coli O157 infections during 1997–2001, nine SF, ?-
glucuronidase-positive O157:H? strains isolated from patients with no 
epidemiological link to each other were investigated further. Within these strains, 
several phenotypic (sorbitol fermentation, ?-glucuronidase-activity, PT88 or PT88 
variant, production of CDT, and lack of Ehly-production) and genotypic 
characteristics (possession of stx2, eae-?, efa1, cdt-V, EHEC-hlyA, etpD, sfpA, or 
lack of katP, espP) were very similar. However, among these isolates strains 
negative for stx also occurred. Seven strains clustered in the PFGE profiling with 
58
highly similar SIs (92% to 98%), banding patterns differing with one to seven bands. 
Within two remaining strains, (i.e. first [IH 53440] and last [IH 57201] strain 
isolated), PFGE profiles with 14 bands difference were seen (Figure 4).  
Figure 4. PFGE fingerprint patterns of the sorbitol-fermenting E. coli O157 human 
strains isolated in Finland. Lanes 1, 12: PFGE standard Salmonella Braenderup 
(H9812); 2, IH 53440; 3, IH 56776; 4, IH 56909; 5, IH 56969; 6, IH 57086; 7, IH 
57201; 8, IH 56905; 9, IH 57075; 10, IH 57084; 11, E. coli O157:H7 control strain 
(G 5244). 
                    1      2     3       4     5      6     7      8      9    10    11    12    
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3.2 Non-O157 strains (II, III, IV) 
During 1990–2002, 73 human EHEC non-O157 infections of domestic (59 cases; 
81%) and foreign (14 cases; 19%) origin were detected. The causative strains 
belonged to 22 O groups, 16 H antigens, and 34 O:H serotypes. In addition, strains 
of serogroup O157:H7/H? caused over 120 infections (Table 8). The most common 
non-O157 O groups of the strains were O103 (n=19), O145 (n=9), and O26 (n=8) 
(Figure 5). In addition, two new serotypes of EHEC strains were found: O102:H7 
and O181:H49. Almost all isolates (71 strains; 97%) fermented sorbitol, and were 
positive for ?-glucoronidase production (67 strains; 92%). Only two strains of the 
serotypes O76:H19 and O145:H? were sorbitol-negative. Of the non-O157 strains, 
approximately half (39 strains, 53%) carried stx2, 30 strains (41%) possessed stx1
only, and four strains of serotypes O43:H2, O111:H?, and ONT:H19 were positive 
for both stx2 and stx1. The stx1 gene was common among strains of O26 (8/8 
isolates), O103 (16/19), and O15 (2/3). The majority (48/73 strains; 66%) possessed 
eae, and 53 strains (73%) produced Ehly. 
Table 8.  Serotypes and corresponding number of EHEC strains of domestic and  
               foreign origin isolated during 1990–2002. 
Serotype  N Serotype  N Serotype  N 
O2:H27 1 O102:H7  1 O157:H? 13 
O2:H29  1 O103:H2  18 O165:H25  1 
O8:H9  1 O103:H?    1 O174:H2 1 
O15:H?   3 O107:H27 1 O174:H21 2 
O20:H7  2 O111:H8  1 O178:H19 2 
O26:H11  7 O111:H?    1 O181:H49  1 
O26:H?    1 O116:H21  1 R:H2  1 
O43:H2  1 O145:H28    4 R:H4 3 
O76:H19     1 O145:H?    5 R:H18 1 
O91:H21     1 O153:H33 1 R:H21  1 
O91:H40     1 O156:H25   1 R:H49 1 
O101:H?    1 O157:H7  114 R:H? 3 
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Figure 5. Distribution of serotypes of EHEC non-O157 strains (n=73) isolated from  
                Finnish patients during 1990–2002. 
4. Virulence profiles of EHEC strains (III) 
In a comparison of characteristics of EHEC O157 or non-O157 strains with severe 
clinical picture (bloody diarrhea, HUS, TTP) of the patients (n=173), 10 stx-positive 
virulene profiles were associated with 71% of all infections (Figure 6). Of these, a 
virulence profile of the O157 group (O157:H7:PT2:stx2:stx2c:eae:Ehly) was 
significantly (P=0.02) more frequently associated with a severe clinical picture than 
were other profiles. In addition, the risk factor for severe symptoms was an age of 
less than five years and infection by this O157:H7 strain type. Strains of this 
virulence profile also caused the deaths of two children. However, among the non-
O157 group, seven pheno- and genotypic virulence profiles of EHEC non-O157 
strains were associated with patients suffering from HUS or TTP, but none of these 
infections was fatal. In particular, strains possessing stx2 (O145:H28/H¯:stx2,
O174:H21:stx2c, O Rough:H4:stx2c, O101:H¯:stx2, O Rough:H49:stx2c, O107:H27 
lacking stx [probably due to a loss of the stx gene], and O2:H29: stx2 undigestable) 
were associated with a severe clinical picture of the patients (HUS or TTP).  
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61
Figure 6.  Virulence profiles of EHEC strains (n=173) and symptoms of patients  
                 (n=170). 
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5. Geographical distribution and incidence of domestic EHEC 
infections (IV) 
During 1998–2002, 99 EHEC infections of domestic origin occurred in 14 of the 21 
hospital districts of Finland. Fifty-two were of O157 and 47 non-O157 infections, 
occurring in 13 and nine hospital districts, respectively. Most EHEC infections were 
detected in the Helsinki Region (28%), Kymenlaakso (16%), Central Ostrobothnia 
(8%), North Ostrobothnia (8%), Southwest Finland (8%), South Ostrobothnia (6%) 
and Central Finland (6%). However, the incidence was highest (10.3 / 105
population) in Central Ostrobothnia (Figure 7). 
Strains of serogroup O157 were associated with three clusters (C1-C3). In C1, the 
strains of same subtypes (O157:H7:PT2:stx2:stx2c:eae:1.1) caused three  of  a total of 
four infections. The remaining strain (O157:H¯:PT88:stx2:eae:1.13) was isolated 
from a child whose mother was infected with a strain of the former C1 type. In C2, 
strains of subtypes (O157:H7:PT4:stx2:eae:1.57 [3 strains], O157:H7:PT4:stx2:
eae:1.58 [1 strain] caused the infections. Among these strains, a two-band difference 
was observed in the PFGE patterns of the isolates. In C3 with three cases, an 
identical strain of subtype O157:H7:PT14:stx1,2:eae:1.67 caused all the infections. 
The clusters were detected in 1998 (C1, C2) and 2001 (C3). However, no outbreak 
clusters caused by strains of non-O157 occurred. Overall, the most common (11 
isolates) and widely distributed (in five hospital districts) subtype was 
O157:H7:PT2:stx2:stx2c:eae:1.1 which also caused C1. 
During this study period (1998–2002), the incidence of the EHEC infections was 
highest in 1998 (0.64). In this year alone, the incidence of O157 (0.47) cases was 
higher than that of the non-O157 (0.17) cases. Since 1999, the incidence of all 
EHEC infections declined (0.62) being lowest (0.17) in 2002. EHEC infections were 
more prevalent during the summer months (June–August) than in other seasons. 
However, between infections caused by strains of EHEC O157 or non-O157, no 
clear seasonal variation was seen. Of all 26 serotypes detected, only strains of O 
groups O157, O103, and O145 caused infections in 2002 (Figure 8).  
6. Vehicles for and transmission of EHEC infection (IV) 
Of the 99 domestically acquired EHEC infections, nearly half, 49%, were family-
related cases detected in 26 families. Sporadic infections represented 39%, and the 
remaining 11% was associated with small clusters. The vehicles for these infections 
were analyzed using in-depth interviews. No statistical difference between the 
exposure factors for O157 or non-O157 infection was observed. However, of the 53 
sporadic or index patients interviewed, cattle or other animal contact was reported 
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by 42 patients; of them 79% were children under 10 years old.  In addition, of the 53 
patients, 86% had consumed ground meat products (three had eaten raw ground 
meat), and 18% unpasteurized milk. It was highly suspected that the C1 cluster was 
due to person-to-person spread. Also, within families, person-to-person 
transimission was a putative infection route. The C2 was associated with possible 
consumtion of hamburgers. For the C3, a food-borne source was implicated as a 
vehicle. 
Figure 7. Incidence and number of domestic EHEC O157 / non-O157 infections in  
               21 hospital districts of Finland during 1998–2002. 
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DISCUSSION
1. Epidemiology of EHEC infections 
In the epidemiological typing of EHEC O157:H7/H? strains, phage typing has been 
exploited as an internationally standardized epidemiological surveillance method 
(Ahmed et al. 1987, Khakhria et al. 1990, Willshaw et al. 1997). However, because 
within a PT there may exist genotypic variations of the bacterial strains, combined 
use of phage typing and molecular genetic methods, such as PFGE and subtyping of 
the stx genes, often provides advantages for epidemiological tracing over the use of 
one system alone (Liesegang et al. 2000). In Finland, in epidemiological 
surveillance it is possible to compare human and non-human EHEC–bacteria using 
the electronic, standardized PFGE network nationally (Rantala et al. 2000) and 
internationally among the Enter-net participants in Europe (PulseNet 2002, Fisher 
and Threlfall 2005, www.hpa.org.uk/inter/enter-net_menu.htm). For example, by 
using the pheno- and genotypic profiling of the O157 strains of Finnish human and 
non-human isolates, nine human EHEC O157 infections have been traced to five 
cattle farms (Lahti et al. 2002). In addition, geno- and phenotypic methods have also 
been exploited in the study of the sources of the EHEC non-O157 infections, where 
cattle were indicated as a source of EHEC O145 human infections (Heinikainen et 
al. 2004).  
In our study of international phenotypic and genotypic comparison of the EHEC 
strains isolated during 1990–1999, the overall distribution of O157 PTs occurring in 
Finland was similar to that found in several other countries in Europe, Asia and 
America (Barrett et al. 1994, Smith et al. 1998, Cheasty et al. 1999, Mora et al. 
2004). Just as this study points out that the PT2 type is the most prevalent, the study 
by Cheasty et al. (1999) showed that PT2 isolates were prevalent also in England 
and Wales, and in Germany, whereas PT4 prevailed in Sweden, PT14 in Denmark, 
and PT32 in Ireland. In Finland, some PT4 isolates were also associated with a 
cruise between Finland and Sweden suggesting that the infections of Finnish 
passengers acquired during the cruise may have originated from the same unknown 
sources as those in Sweden. In the study of 50 human isolates from cases of HUS in 
the Netherlands, Belgium, and Germany, altogether seven PTs: PT2 (44%), PT4 
(33%), PT8 (7%), PT14 (4%), PT32 (4%), PT49 (4%), PT54 (4%) were identified 
(Heuvelink et al. 1995). Of these, five (PT2, 4, 8, 14, 49) corresponded to PTs found 
among human isolates in Finland. PT2, the most common PT in Finland, associated 
with the Finnish outbreak in 1997 (Keskimäki et al. 1998, Paunio et al. 1999), also 
predominated in the United Kingdom in previous years, accounting for 46% of all 
1,266 human isolates during 1992–1994 (Thomas et al. 1996), and was the most 
common type also in 1996 (Smith et al. 1998).  In addition, the PT2 strain with stx2
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and stx2c genes caused six of 11 outbreaks in England and Wales in 1995 (Thomas et 
al. 1996). The fact that these strains and the majority of the Finnish O157:H7:PT2 
strains possessed the genes stx2 and stx2c, may suggest that they have originated from 
the same source. The other common phage types in Finland, PT4 and PT49, have 
also been common in England and Wales (Strockbine et al. 1998). The reason for 
the sudden emergence of Finnish EHEC strains of O157:H7:PT2, which were 
genotypically of PFGE type 1.1 and carried stx2 and stx2c, however, is not known for 
certain. This emergence occurred about two years after Finland had joined the 
European Union and animal and food trade barriers were removed. Also, the 
similarity of the strains that belong to different PTs in Finland and other European 
countries might be due to this event.  
Among the O157 strains in Finland, approximately 10% have been nonmotile O157 
variants of which 75% have fermented sorbitol (Eklund et al. 2003). In other 
European countries, strains of SF O157:H¯ have covered about 30% of all O157 
strains (Karch and Bielaszewska 2001). Interestingly, in the epidemiological 
comparison of the SF O157:H¯ strains obtained in Finland, numerous pheno- and 
genotypic characteristics of the Finnish strains were similar with those strains 
occurring in Germany, suggesting a transmission of the strains at international level 
and supporting their relatedness with similar strains which have recently emerged in 
Europe.
In a nationwide geographical comparison of EHEC O157 and non-O157 infections, 
these infections occurred in 14 and nine of all hospital districts of Finland, 
respectively. Most of the infections were detected in the Helsinki Region, the 
population-based incidence being highest in northwest Finland. The high occurrence 
especially in northwest Finland might have been due to high cattle density. Also in 
other countries, an association between cattle density and human infections has been 
reported (Michel et al. 1999, Valcour et al. 2002, Kistemann et al. 2004). In general, 
in Europe, the prevalence of EHEC O157 and non-O157 bacteria in cattle has been 
even 70% in France (Pradel et al. 2000), 58% in Switzerland (Kuhnert et al. 2005), 
49% Denmark (Møller-Nielsen and Frydendahl 2000), and 18% in Germany 
(Zschöck et al. 2000). The prevalence of EHEC O157 strains has been 6% in 
Belgium and Poland (Tutenel et al. 2002). In our country, the occurrence of EHEC 
O157 in cattle feces has been approximately 1 % (Lahti et al. 2001), and cattle 
during slaughter have excreted strains of serogroup O157 from 10 to 39% (Lahti et 
al. 2003), and EHEC non-O157 from 30 to even 90% (Pelkonen 2002). Of non-
O157 serotypes detected in Finnish cattle, eight have also occurred among Finnish 
human isolates (Pelkonen 2002). However, no clear reason for the high geographical 
occurrence of the infections was seen. In addition, enhanced EHEC diagnostics 
based on not only the serological detection of O157, but also the Stx detection from 
stool cultures in those hospital districts might have also affected the high detection 
rate of the infections.  
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Stx positive non-O157 strains have also been of growing concern (Blanco et al. 
2004). For example, in Spain EHEC strains have been the third most frequently 
isolated enteropathogenic bacteria, 78% of which have been of strains of EHEC 
non-O157 (Blanco et al. 2004). In Sweden, sporadic EHEC non-O157 infections 
have been as frequent as those of O157 during 1997-1998 (Welinder-Olsson et al. 
2002). Strains of non-O157 have caused a large proportion of EHEC infections also 
in the Netherlands and in Denmark (Anon. 2003a). In Norway, in the past decade, 
approximately 100 EHEC cases have been reported, about one third being of non-
O157 infections (Kløvstad et al. 2003). In addition, in the USA, EHEC strains of 
non-O157 group have accounted for up to 25% of HUS cases (Karmali 2004). In 
Oceania, EHEC non-O157 infections have been considered commoner than O157 
infections (Tozzi et al. 2001). Of all EHEC infections studied, strains of EHEC non-
O157 caused high proportion, 40%. The most common O groups detected belonged 
to O groups O26, O103, and O145, which have typically prevailed also in other 
European countries as causes of sporadic infections and outbreaks (Caprioli and 
Tozzi 1998, Zhang et al. 2000, Tozzi et al. 2001, Gerber et al. 2002, Prager et al. 
2002, Jenkins et al. 2003). However, although EHEC non-O157 infections 
represented considerable share of the infections in Finland, no outbreaks caused by 
these pathogens occurred.  
2. Microbiological properties of EHEC strains 
Based on phenotypical properties of EHEC bacteria, recognition of sorbitol-negative 
O157:H7 strains has been well covered worldwide. However, sorbitol-positive 
strains of O157:H? and the majority of EHEC non-O157 bacteria are still most 
probably under-diagnosed in human infections (Scheutz et al. 2004), although 
techniques based on the detection of stx genes and Stx toxins, have proved to be 
crucial instruments in EHEC diagnostics. However, in addition to the mere toxin 
detection, the isolation of EHEC bacteria is of great importance. Namely, 
determining the relatedness of the bacterial strains by serotyping, Stx typing, phage 
typing, and genotyping quickly provides strict microbiological information to be 
used in conjunction with epidemiological data in order to prevent more infections, in 
surveillance of the sources of the infections, and in determining the virulence factors 
of the causative strain. 
The strains of serotype O157:H7 have commonly carried the stx2 virulence genes 
among strains originating in Great Britain (Willshaw et al. 2001) and Germany 
(Liesegang et al. 2000), although in Germany strains of this serogroup have also 
possessed both genes stx1 and stx2 (Beutin et al. 2004). Also in our study strains of 
serotypes O157:H7/H? typically carried stx2. Instead, strains of serotype 
O157:H7/H? have typically carried both stx1 and stx2 especially among the isolates 
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originating from the USA, Australia (Kim et al. 2001), and Spain (Blanco et al. 
2004), which suggests that strains occurring in Finland are similar to those occurring 
in Europe. 
Among the SF O157:H? strains occurring in continental Europe certain phenotypic 
(sorbitol fermentation, PT88, production of CDT, and lack of Ehly-production) and 
genotypic characteristics (possession of stx2, eae-?, efa1, cdt-V, EHEC-hlyA, etpD,
sfpA, or lack of katP, espP) have been typical (Karch and Bielaszewska 2001). Also 
among the Finnish SF O157:H? strains studied, these pheno- and genotypic 
characteristics were very similar, suggesting the pheno- and genotypic similarity and 
putative clonality of the strains occurring in continental Europe and Finland. In 
addition, in a study by Liesegang et al., 2002, the data supported the hypothesis that 
clonal turnover and genetic rearrangement of individual EHEC clones remain rare 
under environmental or epidemiological situations (Liesegang et al. 2000). These 
data also support the clonality of the SF O157 strains occurring in Finland and in 
Europe.
Strains negative for stx also occurred among the isolates studied. O157 strains 
lacking stx genes have also been found in other studies, where the loss of stx genes 
and the respective bacteriophages during laboratory storage, subcultivation, or by 
other environmental factors have been reported (Schmidt et al. 1999b, Willshaw et 
al. 2001).   
During the study period, 73 human EHEC non-O157 infections were detected. 
The causative strains belonged to over 30 O:H serotypes. Among the EHEC non-
O157 strains, only two strains of the serotypes O76:H19 and O145:H? were sorbitol-
negative, sorbitol-positive EHEC non-O157 strains representing the vast majority of 
the isolates. These data support the importance of detection methods not relying on 
sorbitol-negative appearance in the search of EHEC strains. 
Of the non-O157 strains studied, approximately half carried either stx1 or stx2 only. 
The stx1 gene was common among strains of O26, O103, and O15. Also in other 
studies, the carriage of the stx1 gene has been common within the O26 and O103 
group (Schmidt et al. 1999a, Willshaw et al. 2001, Prager et al. 2002). However, 
genetical shift of the carriage of sole stx1 to stx2 only, or acquization of stx2 together 
with stx1 has occurred recently among O26 strains (Zhang et al. 2000), which 
emphasizes the genetical diversity of the EHEC non-O157 bacteria. However, 
among the Finnish EHEC infections caused by strains of O26, no such phenomenon 
had occurred.  
Because even approximately 80% of EHEC strains have been observed to produce 
Ehly (Beutin et al. 1989), this detail can be used in diagnostics in detection of 
putative EHEC strains on Ehly agar plates. Also, enterohemolytic activity might 
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affect the virulence of the strain (Paton and Paton 1998). Of the non-O157 strains in 
our study, the majority produced Ehly. In addition, among the non-O157 strains, the 
carriage of the eae gene was typical. However, although possession of the eae has 
been strong evidence for colonization ability of the strains, strains negative for eae
might possess other aiding mechanisms for colonization of the strains in epithelial 
cells, such as Saa (Paton et al. 2001). 
Recently, 30 new EHEC serotypes were associated with human infections in Spain 
(Blanco et al. 2004), and 31 serotypes in Germany (Beutin et al. 2004), 
strengthening the importance of detection of all EHEC non-O157 infections. Among 
the non-O157 strains in our study, two new EHEC serotypes (O102:H7 and 
O181:H49) were detected that emphasize the versatility of the non-O157 group. Of 
these types, only isolates of O181:H49 have recently occurred also in other 
countries, in Austria and Germany (Scheutz et al. 2004). However, their genotypic 
profile of stx gene possession (stx1 and stx2) differed from that of the Finnish isolate 
(stx2 only), thus suggesting non-clonality of the strains.  
3. Transmission and virulence of EHEC strains 
The severity of the EHEC-infection and its easy transmission, even via hands, have 
had an impact on the decision to define this disease as a generally dangerous 
contagious disease in the Communicable Disease Act in Finland. As EHEC infection 
in humans has typically lead to bloody diarrhea, HUS or TTP, and even death, the 
virulent profile of the strain has become of great importance. For example, EHEC 
strains have caused 1 to 9% of diarrheal cases and 25 to 93% of HUS cases in 
Europe and the USA (Caprioli and Tozzi 1998, Tozzi et al. 2003, Karmali 2004, 
Scheutz et al 2004).  
To study the virulence of EHEC O157 and non-O157 strains isolated in Finland, the 
virulence factors of the strains were explored by pheno- and genotypical methods to 
compare their virulence characteristics with the clinical picture of the patients. In all, 
10 stx-positive virulene profiles were associated with 71% of all infections. Of these, 
a virulence profile O157:H7:PT2:stx2:stx2c:eae:Ehly was significantly more 
frequently associated with a severe clinical picture than were other profiles, 
especially among patients of under five years old. Strains of this virulence profile 
also caused the deaths of two children. Based on the literature, strains carrying stx2
or stx2c have been associated more commonly with HUS than strains harboring stx1
(Law 2000, Karch 2001, Friedrich et al. 2002). Similarly, the most virulent profile 
mentioned above possessed these virulence genes. Instead, among the stx2 gene 
group, stx2d-Ount, a recently found stx2 variant among isolates particularly in Belgium, 
has been considered less virulent compared to that of stx2 or stx2c (Pierard et al. 
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1998). Among the strains studied in Finland, only two isolates possessed stx2d-Ount,
and neither of the patients suffered from HUS or TTP. 
However, although the serogroup O157 strains are very important, seven pheno- and 
genotypic virulence profiles of EHEC non-O157 strains of O groups O2, O101, 
O107, O145, O174, and O Rough were associated with patients suffering from HUS 
or TTP, but none of these infections was fatal. In particular, strains possessing stx2
were associated with severe clinical picture of the patients (HUS or TTP). Also in 
other studies, irrespectively of EHEC O groups, strains carrying stx2, stx2c or stx2dac
genes have been associated with HUS patients (Schmidt et al. 1999a, Cornu et al. 
1999, Friedrich et al. 2002), which emphasized the importance of all EHEC strains 
carrying these genes as severe human pathogens. 
4. Sources of EHEC infections
A major reservoir of EHEC bacteria has been asymptomatic cattle and other 
ruminants (Caprioli et al 2005). A plethora of fecal-contaminated food items 
including ground meat, unpasteurized dairy products, unpasteurized refreshments, 
fruits and vegetables (such as sprouts, lettuce, coleslaw) have been well-known 
vehicles for EHEC infections (Karmali 2004, Schlundt et al. 2004, Caprioli et al. 
2005). In addition, waterborne infections (Garcia-Aljaro et al. 2005), and infections 
associated with rural settings have been of growing importance (Karmali 2004). In 
particular, environment-related exposures have been associated with EHEC 
infections during summer and fall (Karmali 2004, Caprioli et al. 2005). Furthermore, 
through the oral-fecal route, person-to-person contact has been important in 
transmission of EHEC bacteria (Schlundt et al. 2004).  
In Finland, most EHEC infections (80%) were of domestic origin, typically being 
either sporadic or small family-associated infections. However, until now, the source 
of the infections has been confirmed microbiologically in only about ten O157 cases 
(Tast et al. 1997, Lahti et al. 2002), and one EHEC non-O157 case (Heinikainen et 
al. 2004). In all these cases, either unpasteurized milk (Tast et al. 1997) or cattle 
(Lahti et al. 2002, Heinikainen et al. 2004) were implicated as the vehicle for the 
infections. In our study of domestic EHEC infections, according to the in-depth 
interviews, the vehicles for the infections were putative person-to-person contact 
with a diarrheal patient, or consuming ground meat or visiting cattle farms. Also in 
other studies, similar transmissions of EHEC infection have been reported (Caprioli 
et al. 2005, Schlundt et al. 2004). Also asymptomatic human carriers seem to be of 
particular concern in food-handling environments. For example, stx genes were 
detected in 3.5% of more than 5,500 stool samples taken from healthy employees in 
the Swiss meat processing industry (Stephan and Untermann 1999). Thus, healthy 
food handlers must also be regarded as a potential source of EHEC. 
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During 1998–2002, three small clusters caused by strains of serogroup O157 
occurred. Person-to person spread was concluded to be a cause of the transmission 
of the subtype O157:H7:PT2:stx2:stx2c:eae:1.1 strain in 1998. In addition, this 
particular type was the commonest and most widely distributed in hospital districts. 
The emergence of this subtype was seen soon after the first EHEC O157 outbreak in 
Finland had occurred during summer 1997 (Keskimäki et al. 1998, Paunio et al., 
1999). In addition, in 1998 and 2001 two other small EHEC O157 clusters occurred. 
EHEC-contaminated hamburgers were implicated as a putative source of infections 
in the cluster in 1998. The cluster in 2001 occurred in Kymenlaakso, and involved 
EHEC contaminated kebab meat imported from the Netherlands (Hatakka et al. 
2002). 
Among the EHEC infections of domestic origin during 1998–2002, the incidence of 
the infections was highest in 1998 but lowest in 2002. Interestingly, after 1999, 
nationwide hygienic counseling concerning the whole “from farm to fork” chain was 
intensified (Anon. 2003b). A similar decline in the number of EHEC infections was 
observed also in Germany in 2000, probably affected by the national hygiene 
legislation and directives of the European Union (Kothmann 1999). This counseling 
might have diminished the spread of EHEC bacteria in the food chain, resulting in 
fewer human EHEC infections. 
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KEY FINDINGS AND CONCLUSIONS 
In this thesis, epidemiological knowledge and data on microbiological pheno- and 
genotypic characteristics of human EHEC O157 and non-O157 strains isolated in 
Finland was gained. During 1990–2002, 200 microbiologically confirmed EHEC 
infections were diagnosed. Of these, 127 were EHEC O157 and 73 non-O157 
infections. In addition, a double infection occurred in three patients.  
As EHEC bacteria are pheno- and genotypically heterogeneous human pathogens 
causing severe infectious diseases, surveillance and early phase-detection of EHEC 
infections caused by EHEC O157 and non-O157 serogroups is continuously needed, 
thus allowing detailed early diagnosis of EHEC and prevention of new infections. In 
particular, pheno- and genotypic characterization of the human EHEC isolates both 
at a national and international level enables the sources the existing infections to be 
rapidly traced and allows detailed information for the microbiological and statistical 
epidemiological analysis of the sporadic or outbreak -related infections. 
Furthermore, the determination of several virulence associated genes in addition to 
the epidemiological meaning, helps to evaluate the putative virulence ability of the 
strain. Thus, the emergence of EHEC infections also in Finland requires constant 
epidemiological study and characterization of human EHEC isolates.  
Of the infections studied, approximately half of the EHEC O157 and non-O157 
infections were family-related cases. In addition, during the study period of 
indigenously acquired EHEC infections, three small outbreak clusters caused by 
strains of EHEC O157 occurred. These data suggest the easy spread of EHEC O157 
strains. Moreover a particular virulence profile of EHEC O157 group 
(O157:H7:PT2:stx2:stx2c:eae:Ehly) was statistically more frequently associated with 
a severe clinical picture (bloody diarrhea, HUS, TTP) than were other profiles. 
Strains of this virulence profile also caused the deaths of two children. Overall, the 
risk factors for severe symptoms were concluded to be an age of less than five years 
and infection by this O157:H7 strain type, which emphasizes the early detection of 
EHEC infections especially in young children. 
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